<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-07T13:05:47Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5645406" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5645406</identifier>
        <datestamp>2017-10-19</datestamp>
        <setSpec>ncomms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
              <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
              <journal-title-group>
                <journal-title>Nature Communications</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2041-1723</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5645406</article-id>
              <article-id pub-id-type="pmcid">PMC5645406</article-id>
              <article-id pub-id-type="pmc-uid">5645406</article-id>
              <article-id pub-id-type="pmid">29042551</article-id>
              <article-id pub-id-type="publisher-id">831</article-id>
              <article-id pub-id-type="doi">10.1038/s41467-017-00831-x</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6634-0599</contrib-id>
                  <name>
                    <surname>Noh</surname>
                    <given-names>Hyun Ji</given-names>
                  </name>
                  <address>
                    <email>noh@broadinstitute.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tang</surname>
                    <given-names>Ruqi</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Flannick</surname>
                    <given-names>Jason</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>O’Dushlaine</surname>
                    <given-names>Colm</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Swofford</surname>
                    <given-names>Ross</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Howrigan</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Genereux</surname>
                    <given-names>Diane P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Jeremy</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4350-6661</contrib-id>
                  <name>
                    <surname>van Grootheest</surname>
                    <given-names>Gerard</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8505-7265</contrib-id>
                  <name>
                    <surname>Grünblatt</surname>
                    <given-names>Edna</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Andersson</surname>
                    <given-names>Erik</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Djurfeldt</surname>
                    <given-names>Diana R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Patel</surname>
                    <given-names>Paresh D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Koltookian</surname>
                    <given-names>Michele</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>M. Hultman</surname>
                    <given-names>Christina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff11">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pato</surname>
                    <given-names>Michele T.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pato</surname>
                    <given-names>Carlos N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rasmussen</surname>
                    <given-names>Steven A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff13">13</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jenike</surname>
                    <given-names>Michael A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff14">14</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0742-6990</contrib-id>
                  <name>
                    <surname>Hanna</surname>
                    <given-names>Gregory L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stewart</surname>
                    <given-names>S. Evelyn</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff15">15</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3307-5741</contrib-id>
                  <name>
                    <surname>Knowles</surname>
                    <given-names>James A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ruhrmann</surname>
                    <given-names>Stephan</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff16">16</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grabe</surname>
                    <given-names>Hans-Jörgen</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff17">17</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wagner</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff18">18</xref>
                  <xref ref-type="aff" rid="Aff19">19</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rück</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mathews</surname>
                    <given-names>Carol A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff20">20</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Walitza</surname>
                    <given-names>Susanne</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cath</surname>
                    <given-names>Daniëlle C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff21">21</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Feng</surname>
                    <given-names>Guoping</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff22">22</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4343-3776</contrib-id>
                  <name>
                    <surname>Karlsson</surname>
                    <given-names>Elinor K.</given-names>
                  </name>
                  <address>
                    <email>elinor@broadinstitute.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff23">23</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <name>
                    <surname>Lindblad-Toh</surname>
                    <given-names>Kerstin</given-names>
                  </name>
                  <address>
                    <email>kersli@broadinstitute.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff24">24</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Broad Institute of MIT and Harvard, </institution></institution-wrap>415 Main Street, Cambridge, MA 02142 USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution>Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, </institution><institution>Massachusetts Institute of Technology, </institution></institution-wrap>43 Vassar Street, Cambridge, MA 02139 USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution>Renji Hospital, School of Medicine, Shanghai Jiao Tong University, </institution></institution-wrap>145 Shandong Middle Road, Huangpu Qu, Shanghai, 200001 China </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution>GGZ inGeest and Department of Psychiatry, </institution><institution>VU University Medical Center, </institution></institution-wrap>De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Department of Child &amp; Adolescent Psychiatry and Psychotherapy, </institution><institution>University Hospital of Psychiatry Zurich, University of Zurich, </institution></institution-wrap>Neumünsterallee 9, Zurich, 8032 Switzerland </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Neuroscience Center Zurich, </institution><institution>University of Zurich &amp; ETH Zurich, </institution></institution-wrap>Winterthurer Strasse 190, Zurich, 8057 Switzerland </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution>Zurich Center for Integrative Human Physiology, </institution><institution>University of Zurich, </institution></institution-wrap>Winterthurer Strasse 190, Zurich, 8057 Switzerland </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Department of Clinical Neuroscience, Centre for Psychiatry Research, </institution><institution>Karolinska Institutet Tomtebodavägen 18A, </institution></institution-wrap>Stockholm, 17177 Sweden </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2326 2191</institution-id><institution-id institution-id-type="GRID">grid.425979.4</institution-id><institution>Stockholm Health Care Services, </institution><institution>Stockholm County Council, </institution></institution-wrap>Stockholm, 14186 Sweden </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution>Department of Psychiatry, </institution><institution>University of Michigan, </institution></institution-wrap>4250 Plymouth Road, Ann Arbor, MI 48109 USA </aff>
                <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution>Department of Medical Epidemiology &amp; Biostatistics, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, 17177 Sweden </aff>
                <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution>Department of Psychiatry &amp; Behavioral Sciences, </institution><institution>USC, </institution></institution-wrap>2250 Alcazar Street, Los Angeles, CA 90033 USA </aff>
                <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution>Department of Psychiatry &amp; Human Behavior, </institution><institution>Brown Medical School, </institution></institution-wrap>345 Blackstone Boulevard, Box G-BH, Providence, RI 02906 USA </aff>
                <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution>Department of Psychiatry, </institution><institution>Harvard Medical School, </institution></institution-wrap>401 Park Drive, Boston, MA 02215 USA </aff>
                <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution>BC Mental Health &amp; Addictions Research Institute, UBC, </institution></institution-wrap>2255 Wesbrook Mall, Vancouver, BC Canada V6T 2A1 </aff>
                <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution>Department of Psychiatry &amp; Psychotherapy, </institution><institution>University of Cologne, </institution></institution-wrap>Kerpener Street 62, Cologne, 50937 Germany </aff>
                <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.5603.0</institution-id><institution>Department of Psychiatry &amp; Psychotherapy, </institution><institution>University of Medicine Greifswald, </institution></institution-wrap>Fleischmannstrasse 8, Greifswald, 17475 Germany </aff>
                <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2240 3300</institution-id><institution-id institution-id-type="GRID">grid.10388.32</institution-id><institution>Department of Psychiatry &amp; Psychotherapy, </institution><institution>University of Bonn, </institution></institution-wrap>Regina-Pacis-Weg 3, Bonn, 53113 Germany </aff>
                <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution>German Center for Neurodegenerative Diseases, </institution></institution-wrap>Sigmund-Freud-Strasse 27, Bonn, 53127 Germany </aff>
                <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8091</institution-id><institution-id institution-id-type="GRID">grid.15276.37</institution-id><institution>Department of Psychiatry &amp; Genetics Institute, </institution><institution>University of Florida, </institution></institution-wrap>1149 Newell Drive, Gainesville, FL 32610 USA </aff>
                <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ISNI">0000000120346234</institution-id><institution-id institution-id-type="GRID">grid.5477.1</institution-id><institution>Department of Clinical &amp; Health Psychology, </institution><institution>Utrecht University, </institution></institution-wrap>Heidelberglaan 1, Utrecht, CS 3584 The Netherlands </aff>
                <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Stanley Center for Psychiatric Research, </institution><institution>Broad Institute of MIT and Harvard, </institution></institution-wrap>415 Main Street, Cambridge, MA 02142 USA </aff>
                <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0742 0364</institution-id><institution-id institution-id-type="GRID">grid.168645.8</institution-id><institution>Program in Bioinformatics &amp; Integrative Biology and Program in Molecular Medicine, </institution><institution>University of Massachusetts Medical School, </institution></institution-wrap>368 Plantation Street, Sherman Center, Worcester, MA 01605 USA </aff>
                <aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9457</institution-id><institution-id institution-id-type="GRID">grid.8993.b</institution-id><institution>Science for Life Laboratory, </institution><institution>IMBIM, Uppsala University, </institution></institution-wrap>Uppsala, 75236 Sweden </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>17</day>
                <month>10</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>17</day>
                <month>10</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2017</year>
              </pub-date>
              <volume>8</volume>
              <elocation-id>774</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>1</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>1</day>
                  <month>8</month>
                  <year>2017</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2017</copyright-statement>
                <license license-type="OpenAccess">
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Obsessive-compulsive disorder is a severe psychiatric disorder linked to abnormalities in glutamate signaling and the cortico-striatal circuit. We sequenced coding and regulatory elements for 608 genes potentially involved in obsessive-compulsive disorder in human, dog, and mouse. Using a new method that prioritizes likely functional variants, we compared 592 cases to 560 controls and found four strongly associated genes, validated in a larger cohort. <italic>NRXN1</italic> and <italic>HTR2A</italic> are enriched for coding variants altering postsynaptic protein-binding domains. <italic>CTTNBP2</italic> (synapse maintenance) and <italic>REEP3</italic> (vesicle trafficking) are enriched for regulatory variants, of which at least six (35%) alter transcription factor-DNA binding in neuroblastoma cells. <italic>NRXN1</italic> achieves genome-wide significance (<italic>p</italic> = 6.37 × 10<sup>−11</sup>) when we include 33,370 population-matched controls. Our findings suggest synaptic adhesion as a key component in compulsive behaviors, and show that targeted sequencing plus functional annotation can identify potentially causative variants, even when genomic data are limited.</p>
              </abstract>
              <abstract id="Abs2" abstract-type="web-summary">
                <p id="Par2">Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder with symptoms including intrusive thoughts and time-consuming repetitive behaviors. Here Noh and colleagues identify genes enriched for functional variants associated with increased risk of OCD.</p>
              </abstract>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2017</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par3">Obsessive-compulsive disorder (OCD) is a highly heritable (<italic>h</italic>
<sup>2</sup> = 0.27–0.65)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, debilitating neuropsychiatric disorder characterized by intrusive thoughts and time-consuming repetitive behaviors. Over 80 million people worldwide are estimated to suffer from OCD, and most do not find relief with available therapeutics<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, underscoring the urgency to better understand the underlying biology. Genome-wide association studies (GWAS) implicate glutamate signaling and synaptic proteins<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref></sup>, but specific genes and variants have not been validated. Isolating and characterizing such genes are important for understanding the biology and developing treatments for this devastating disease.</p>
              <p id="Par4">In mouse, genetically engineered lines have causally implicated the cortico-striatal neural pathway in compulsive behavior. Mice with a deletion of <italic>Sapap3</italic> exhibit self-mutilating compulsive grooming and dysfunctional cortico-striatal synaptic transmission, with abnormally high activity of medium spiny neurons (MSNs) in the striatum. Resulting compulsive grooming is ameliorated by selective serotonin reuptake inhibitor (SSRI), a first-line medication for OCD<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Similarly, chronic optogenetic stimulation of the cortico-striatal pathway in normal mice leads to compulsive grooming accompanied by sustained increases in MSN activity<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Thus, excessive striatal activity, likely due to diminished inhibitory drive in MSN microcircuitry, is a key component of compulsive grooming. The brain region disrupted in this mouse model is also implicated by imaging studies in human OCD<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p>
              <p id="Par5">Pet dogs are a natural model for OCD amenable to genome-wide mapping due to their unique population structure<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Canine compulsive disorder (canine CD) closely parallels OCD, with equivalent clinical metrics, including compulsive extensions of normal behaviors, typical onset at early social maturity, roughly a 50% rate of response to SSRIs, high heritability, and polygenic architecture<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Through GWAS and targeted sequencing in dog breeds with exceptionally high rates of canine CD, we associated genes involved in synaptic functioning and adhesion with CD, including neural cadherin (<italic>CDH2</italic>), catenin alpha2 (<italic>CTNNA2</italic>), ataxin-1 (<italic>ATXN1</italic>), and plasma glutamate carboxypeptidase (<italic>PGCP</italic>)<sup><xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref></sup>.</p>
              <p id="Par6">Human genetic studies of related disorders, such as autism spectrum disorders (ASD), suggest additional genes. Both ASD and OCD are characterized by repetitive behaviors, and high comorbidity suggests a shared genetic basis<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Genome-wide studies searching for de novo and inherited risk variants have confidently associated hundreds of genes with ASD; this set may be enriched for genes involved in OCD<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
              <p id="Par7">Focusing on genes implicated by model organisms and related disorders could find variants underlying OCD risk, even with smaller sample sizes. Researchers, particularly in psychiatric genetics, are wary of “candidate gene” approaches, which often failed to replicate<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Closer examination of past studies suggests this approach is powerful and reliable when the set of genes tested is large, and the association is driven by rare variation<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. A study testing 2000 candidate genes for association with diabetic retinopathy identified 25 genes, at least 11 of which achieved genome-wide significance in a GWAS of type 2 diabetes, a related disorder<sup><xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>. A targeted-sequencing study of ASD, with 78 genes, identified four genes with recurrent, rare deleterious mutations; these four genes are also implicated by whole-exome sequencing studies<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Candidate gene studies also replicated associations to rare variants in <italic>APP</italic>, <italic>PSEN1</italic>, and <italic>PSEN2</italic> for Alzheimer’s disease<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, <italic>PCSK9</italic> for low-density lipoprotein–cholesterol level<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, and copy-number variants for autism and schizophrenia<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
              <p id="Par8">Detecting associations driven by rare variants requires sequencing data, which captures nearly all variants. Although whole-genome sequencing studies of complex diseases are still prohibitively expensive, it is feasible to target a subset of the genome. Sequencing also facilitates identification of causal variants, accelerating discovery of new therapeutic avenues<sup><xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref></sup>. For example, finding functional, rare variants in <italic>PCSK9</italic> led to new therapies for hypercholesterolemia<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. One approach is to target predominantly coding regions (whole-exome sequencing). Although successful in finding causal variants for rare diseases<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, this approach misses the majority of disease-associated variants predicted to be regulatory<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. A targeted-sequencing approach that captures both the regulatory and coding variation of a large set of candidate genes offers many advantages of whole-genome sequencing, and is feasible when cohort size and resources are limited.</p>
              <p id="Par9">Here we report a new strategy that overcomes limitations of less comprehensive candidate gene studies and exome-only approaches, and identifies functional variants associated with increased risk of OCD. We start by compiling a large set of 608 genes (~3% of human genes) using studies of compulsive behavior in dogs and mice, and studies of ASD and OCD in humans. By focusing on this subset of genes, targeting both coding and regulatory regions, and applying a new statistical method that incorporates regulatory and evolutionary information, we identify four associated genes, including <italic>NRXN1</italic>, the first genome-wide-significant association reported for OCD.</p>
            </sec>
            <sec id="Sec2" sec-type="results">
              <title>Results</title>
              <sec id="Sec3">
                <title>Targeted-sequencing design</title>
                <p id="Par10">We compiled a list of 608 genes using three strategies (65 were implicated more than once) (Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref> and Supplementary Methods):<list list-type="order"><list-item><p id="Par11">263 “model-organism genes”, including 56 genes associated in canine CD GWAS and 222 genes implicated in murine-compulsive grooming.</p></list-item><list-item><p id="Par12">196 “ASD genes” from SFARI database (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/">https://gene.sfari.org/</ext-link>) as of 2009.</p></list-item><list-item><p id="Par13">216 “human candidate genes” from small-scale OCD candidate gene studies (56 genes), family-based linkage studies of OCD (91 genes), and by other neuropsychiatric disorders (69 genes).</p></list-item></list>
</p>
                <p id="Par14">We targeted coding regions and 82,723 evolutionarily constrained elements in and around these genes, totaling 13.2 Mb (58 bp–16 kb size range, median size 237 bp), 34% noncoding<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p>
              </sec>
              <sec id="Sec4">
                <title>Variant detection</title>
                <p id="Par15">We sequenced 592 European ancestry DSM-IV OCD cases and 560 ancestry-matched controls using pooled sequencing, with 16 samples per bar-coded pool (37 “case” pools; 35 “control” pools). Overall, 95% of target regions were sequenced at <italic>&gt;</italic>30× read depth per pool (median 112×; ~7× per individual; Supplementary Fig. <xref rid="MOESM1" ref-type="media">1</xref>), sufficient to identify variants occurring in just one individual, assuming 0.5–1% per base machine error rate.</p>
                <p id="Par16">We called 124,541 single nucleotide polymorphisms (SNPs) using Syzygy (84,216)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and SNVer (81,829)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. For primary analyses, we focused on 41,504 “high-confidence” SNPs detected by both, with highly correlated allele frequencies (AF) (Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> &lt; 2.2 × 10<sup>−16</sup>; Supplementary Fig. <xref rid="MOESM1" ref-type="media">2</xref>). We see no significant difference between case and control pools, indicating no bias in variant detection.</p>
              </sec>
              <sec id="Sec5">
                <title>Variant annotation</title>
                <p id="Par17">We used three annotations shown to be enriched for disease-associated variation to identify likely functional variants in our targeted regions: coding, evolutionary conserved, and/or DNase1 hypersensitivity site (DHS)<sup><xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR27">27</xref></sup>. We annotated 67% (27,626) of high-confidence variants, with 16% coding (49% of those were non-synonymous), 36% DHS, and 80% evolutionary conserved or divergent (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>). We measured evolutionary constraint using mammalian GERP++ scores<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>; scores &gt;2 were “conserved” and scores &lt;–2 were “divergent”.<fig id="Fig1"><label>Fig. 1</label><caption><p>PolyStrat analysis of pooled-targeted-sequencing data. <bold>a</bold> Venn diagrams showing the number of SNPs annotated as functional and/or conserved by PolyStrat. Each of the four <italic>dashed circles</italic> represents the 41,504 total high-confidence SNPs detected. Within each <italic>circle</italic>, SNPs are stratified by their annotations. Each <italic>colorful interior circle</italic> represents SNPs annotated as exonic (<italic>blue</italic>), regulatory (<italic>green</italic>), conserved (<italic>red</italic>), or diverged (<italic>gray</italic>) bases. SNPs with multiple annotations are represented by <italic>circle overlaps</italic>, and SNPs without any of the included annotations are within the <italic>white space</italic> of the <italic>dashed outer circle</italic>. <bold>b</bold> PolyStrat <italic>p</italic>-values for 608 genes (<italic>circles</italic>) stratified by the 16 (12 shown) annotation categories tested show that just five genes (<italic>NRXN1</italic>, <italic>HTR2A</italic>, <italic>LIPH</italic>, <italic>CTTNBP2</italic>, and <italic>REEP3</italic>) have <italic>p</italic>-values below the experiment-wide significance threshold after correction for multiple testing (<italic>red dashed line</italic>). Two moderately associated, OCD-relevant genes discussed in the text are also noted (<italic>STRN</italic> and <italic>CACNA1C</italic>). “Evo” (=evolutionary) are SNPs either conserved (“Cons”) or divergent (“Div”). The vast majority of genes tested fail to exceed the significance threshold, with the median <italic>p</italic>-value for each category shown as a <italic>dark black line</italic> separating two <italic>boxes</italic> representing the 25–75% quantile. <italic>Notch</italic> in <italic>boxes</italic> shows the 95% confidence interval around median. <bold>c</bold>
<italic>p</italic>-values for the five genes robustly implicated in animal models of OCD are significantly lower than <italic>p</italic>-values for the rest of the genes in our sequencing set (603 genes), and this difference increases when just rare variants are tested. The <italic>solid horizontal line</italic> shows median <italic>p</italic>-value, the <italic>boxed area</italic> the 25–75% quantiles, and the <italic>vertical black lines</italic> extend from the minimum to maximum <italic>p</italic>-values observed. AF, allele frequency</p></caption><graphic xlink:href="41467_2017_831_Fig1_HTML" id="d29e1225"/></fig>
</p>
              </sec>
              <sec id="Sec6">
                <title>Gene-based burden analysis</title>
                <p id="Par18">To identify genes with a significant load of non-reference alleles in OCD cases, relative to controls, we developed PolyStrat, a one-sided gene-based burden test that controls for gene length (Supplementary Fig. <xref rid="MOESM1" ref-type="media">3a</xref>) and incorporates variant annotation. We used four variant categories: (i) all (Overall), (ii) coding (Exon), (iii) regulatory (variants in DHS), and (iv) rare (1000 Genomes Project<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> AF &lt; 0.01). Each category is further stratified by evolutionary status: (i) all detected variants; (ii) slow-evolving conserved (Cons); (iii) fast-evolving divergent (Div); and (iv) evolutionary (Evo). “Evo” is the subset of “all” variants annotated as either “conserved” or “divergent”. In total, PolyStrat considers 16 groups stratified by predicted function and evolutionary conservation.</p>
                <p id="Par19">PolyStrat <italic>p</italic>-values are corrected for multiple testing empirically using a permutation-based method that accurately measures experiment-wide statistical significance across correlated gene-based tests, while controlling for type 1 errors (Supplementary Methods). For most variant categories, quantile–quantile plots revealed good correspondence between observed values and the empirical null, with a small number of genes exceeding the expected distribution in a subset of the burden tests (Supplementary Figs. <xref rid="MOESM1" ref-type="media">3</xref>b and <xref rid="MOESM1" ref-type="media">4</xref>).</p>
                <p id="Par20">Five of the 608 sequenced genes (0.82%) show significant burdens of variants in OCD patients (Table <xref rid="Tab1" ref-type="table">1</xref>; Fig. <xref rid="Fig1" ref-type="fig">1b</xref>), including two with excess coding variants (<italic>NRXN1</italic> and <italic>HTR2A</italic>) and two with excess regulatory variants (<italic>CTTNBP2</italic> and <italic>REEP3)</italic> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). <italic>REEP3</italic> is the only gene with excess divergent (potentially fast evolving) variants. No genes had a significant burden of rare variants (Supplementary Fig. <xref rid="MOESM1" ref-type="media">4</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Five genes with significant variant burden in OCD cases in pooled-sequencing data</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genes</th><th>Description</th><th>Total SNPs in PolyStrat</th><th>Case-abundant SNPs in PolyStrat</th><th>PolyStrat category (one-sided burden P)</th></tr></thead><tbody><tr><td><italic>LIPH</italic><sup>a</sup></td><td>Lysophosphatidic acid production<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>
</td><td>7</td><td>6 (86%)</td><td>Overall (4 × 10<sup>−4</sup>)</td></tr><tr><td><italic>NRXN1</italic></td><td>Encodes a synapse adhesion molecule</td><td>8</td><td>8 (100%)</td><td>Exon-Cons (2 × 10<sup>−4</sup>)</td></tr><tr><td/><td/><td>13</td><td>10 (77%)</td><td>Exon-All (2 × 10<sup>−4</sup>)</td></tr><tr><td/><td/><td>12</td><td>10 (83%)</td><td>Exon-Evo (3 × 10<sup>−4</sup>)</td></tr><tr><td><italic>HTR2A</italic></td><td>Indirect target for SSRI medications<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>
</td><td>4</td><td>4 (100%)</td><td>Exon-Cons (9 × 10<sup>−4</sup>)</td></tr><tr><td><italic>CTTNBP2</italic></td><td>Modulates postsynaptic cortactin<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>
</td><td>5</td><td>3 (60%)</td><td>DHS-Cons (5 × 10<sup>−4</sup>)</td></tr><tr><td/><td/><td>15</td><td>8 (53%)</td><td>DHS-All (9 × 10<sup>−4</sup>)</td></tr><tr><td><italic>REEP3</italic></td><td>Regulates cellular vesicle trafficking</td><td>3</td><td>3 (100%)</td><td>Overall-Div (1 × 10<sup>−4</sup>)</td></tr><tr><td/><td/><td>4</td><td>4 (100%)</td><td>DHS-Evo (6 × 10<sup>−4</sup>)</td></tr><tr><td/><td/><td>6</td><td>5 (83%)</td><td>DHS-All (8 × 10<sup>−4</sup>)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Significance of association possibly inflated by linkage between markers</p></table-wrap-foot></table-wrap>
</p>
                <p id="Par21">We validated the 46 SNPs contributing to significant gene-burden tests (7 in <italic>LIPH</italic>, 13 in <italic>NRXN1</italic>, 4 in <italic>HTR2A</italic>, 15 in <italic>CTTNBP2</italic>, and 7 in <italic>REEP3</italic>) by individual genotyping of 571 OCD and 555 control samples (98% of the cohort). Nine variants failed Sequenom assay design or had low genotyping rates. For the remaining 37, the genotyping and pooled-sequencing frequencies are nearly perfectly correlated (Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> &lt; 2.2 × 10<sup>−16</sup>; Supplementary Fig. <xref rid="MOESM1" ref-type="media">5</xref>; Supplementary Data <xref rid="MOESM4" ref-type="media">1</xref>).</p>
                <p id="Par22">We confirmed that our significant gene-burden test findings are not driven by population structure (Supplementary Methods) or linkage disequilibrium (LD), with one notable exception. We measured pairwise <italic>r</italic>
<sup>2</sup> between SNPs contributing to the burden test in our top five genes, and found strong LD (<italic>r</italic>
<sup>2</sup> &gt; 0.8) between one pair, in <italic>LIPH</italic>. There was no strong LD in <italic>NRXN1</italic>, <italic>HTR2A</italic>, <italic>CTTNBP2</italic>, and <italic>REEP3</italic>.</p>
                <p id="Par23">Genes included from model-organism studies (263 genes) and larger ASD studies (196 genes) were significantly more associated than genes from human candidate gene studies (216 genes) (Kruskal–Wallis <italic>p</italic> = 5.6 × 10<sup>−15</sup>). This is consistent with previous work showing that genes found through smaller candidate gene studies replicate poorly<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. It also suggests that, when a genome-wide study of the disease of interest is not available, targeting genes implicated in a model organism may be as effective as targeting genes implicated in a comorbid, phenotypically similar human disorder.</p>
                <p id="Par24">The five genes most strongly implicated in canine CD and murine-compulsive grooming (<italic>CDH2</italic>, <italic>CTNNA2</italic>, <italic>ATXN1</italic>, <italic>PGCP</italic>, and <italic>Sapap3</italic>) have significantly lower <italic>p</italic>-values than the other 603 sequenced genes (Wilcoxon unpaired, one-sided <italic>p</italic> = 2.6 × 10<sup>−4</sup>). The difference becomes more significant when only rare variants are tested (Wilcoxon unpaired, one-sided <italic>p</italic> = 3.2 × 10<sup>−5</sup>) (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). This is consistent with the hypothesis that severe disease-causing variants, rare in humans due to negative selection, may persist at higher frequencies in model organisms where selection is relaxed.<fig id="Fig2"><label>Fig. 2</label><caption><p>Targeted-sequencing detects both coding and regulatory candidate variants in the four top-scoring genes <bold>a</bold>
<italic>NRXN1</italic>
<bold>b</bold> HTR2A <bold>c</bold>
<italic>CTTNBP2</italic> and <bold>d</bold>
<italic>REEP3</italic>. Sequenced “Target regions” are shown as <italic>gray boxes</italic> above the <italic>red</italic> “–log<sub>10</sub>
<italic>p</italic>
<sub>single</sub>” track displaying the association <italic>p</italic>-values for all detected variants and the <italic>blue</italic> “AF ca/co ratio” track showing the ratio of OCD AF over control AF. “Candidate variants” are annotated as missense (<italic>red</italic>), synonymous (<italic>green</italic>), untranslated (<italic>purple</italic>), DHS variants (<italic>blue</italic>), or unannotated (<italic>black</italic>). Lastly, the gene is shown as a <italic>horizontal blue line</italic> with exons (<italic>solid boxes</italic>) and <italic>arrows</italic> indicating direction of transcription. The highest scoring isoform of <italic>NRXN1</italic>, <italic>NRXN1a-2</italic>, is shown in (<bold>a</bold>)</p></caption><graphic xlink:href="41467_2017_831_Fig2_HTML" id="d29e1717"/></fig>
</p>
                <p id="Par25">Applying the burden test across multiple genes with shared biological functions, we identified gene sets with high-variant load in OCD patients. We tested all 989 Gene Ontology (GO) sets that are at least weakly enriched (enrichment <italic>p</italic> &lt; 0.1) in our 608 sequenced genes (Supplementary Data <xref rid="MOESM5" ref-type="media">2</xref>) and found two with high-variant burdens: “GO:0010942 positive regulation of cell death” (uncorrected <italic>p</italic> = 3 × 10<sup>−4</sup>, corrected <italic>p</italic> &lt; 0.03) and “GO:0031334 positive regulation of protein complex assembly” (uncorrected <italic>p</italic> = 7 × 10<sup>−4</sup>, corrected <italic>p</italic> &lt; 0.06). Overlaying the burden test results onto the GO network topology highlights functional themes linking the enriched gene sets: regulation of protein complex assembly and cytoskeleton organization; neuronal migration; action potential; and cytoplasmic vesicle (Supplementary Fig. <xref rid="MOESM1" ref-type="media">6</xref>).</p>
              </sec>
              <sec id="Sec7">
                <title>Validation of candidate variants by genotyping</title>
                <p id="Par26">We genotyped the top 67 candidate functional variants from the five significant genes, including 42 rare SNPs (AF &lt; 0.01), in the pooled-sequencing cohort (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>). This yielded, after QC, individual genotypes for 63 SNPs in 571 cases and 555 controls (98% of the cohort; genotyping rate &gt;0.94 for all SNPs). We see near perfect correlation with the pooled sequencing for both allele frequencies (Fig. <xref rid="Fig3" ref-type="fig">3b, c</xref>; OCD AF, Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> = 2.7 × 10<sup>−89</sup>; Control AF, Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> = 2.5 × 10<sup>−89</sup>) and the AF differences (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>; OCD AF–control AF, Pearson’s <italic>ρ</italic> = 0.93, <italic>p</italic> = 4.8 × 10<sup>−28</sup>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Validated top candidate variants disrupt functional elements active in brain. <bold>a</bold> Frequencies of the top candidate variants show that most are rare (AF &lt; 0.01) in our cohort, illustrating the value of sequencing rather than array-based genotyping for detecting candidate variants. <bold>b</bold>–<bold>g</bold> Allele frequencies from pooled sequencing of individuals in the original cohort (cohort 1) are validated by genotyping in <bold>b</bold> cases and <bold>c</bold> controls, and by <bold>d</bold> allele-frequency differences between cases and controls. For the vast majority of variants, the pooled-sequencing allele frequencies are also highly correlated with frequencies observed in 33,370 ExAC individuals in both cases (<bold>b</bold>, <italic>gray dots</italic>) and controls (<bold>c</bold>, <italic>gray dots</italic>). Genotyping an independent cohort (cohort 2) of cases and controls reveals genotyping allele frequencies from cohort 1 are correlated in <bold>e</bold> cases and <bold>f</bold> controls; and for <bold>g</bold> allele-frequency differences between cases and controls. Correlation test was performed using Fisher’s <italic>Z</italic> transform. <bold>h</bold> The top candidate variants in <italic>CTTNBP2</italic> and <italic>REEP3</italic>, the two genes enriched for regulatory variants, disrupt DNase hypersensitivity sites (<italic>DHS</italic>), enhancers, and transcription factor-binding sites (TFBS) annotated as functional in brain tissues and cell lines in ENCODE and Roadmap Epigenomics. All 17 variants disrupt elements active in either the dorsolateral prefrontal cortex and/or substantia nigra, which are among the <bold>i</bold> brain regions involved in the CSTC circuit implicated in OCD, illustrated with <italic>black arrows</italic>. Image adapted from Creative Commons original by Patrick J. Lynch and C. Carl Jaffe, MD. <bold>j</bold> The CSTC circuit requires a balance between a direct, GABAergic signaling pathway and an indirect pathway that involves both GABAergic and glutamate signaling. In OCD patients, an imbalance favoring the direct over the indirect pathway disrupts the normal functioning of the CSTC circuit<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>
</p></caption><graphic xlink:href="41467_2017_831_Fig3_HTML" id="d29e1870"/></fig>
</p>
                <p id="Par27">We genotyped these 63 SNPs in an independent cohort of 727 cases and 1105 controls of European ancestry, and found strong correlation with the first genotyping cohort for both AF (Fig. <xref rid="Fig3" ref-type="fig">3e, f</xref>; OCD AF, Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> = 1.0 × 10<sup>−82</sup>; control AF, Pearson’s <italic>ρ</italic> = 0.999, <italic>p</italic> = 1.8 × 10<sup>−94</sup>) and AF differences (Fig. <xref rid="Fig3" ref-type="fig">3g</xref>; OCD AF–control AF, Pearson’s <italic>ρ</italic> = 0.4, <italic>p</italic> = 0.001). The risk allele from the first cohort is significantly more common in cases in the second cohort (Wilcoxon paired one-sided test for 63 SNPs, <italic>p</italic> = 0.005). More specifically, of 54 SNPs that had a higher frequency of the non-reference allele in cases in the first cohort, 61% also had a higher frequency of the non-reference allele in cases in the second cohort. The 33 SNPs that failed to validate in either of the two cohorts had smaller allele-frequency differences in the first cohort (one-sided unpaired <italic>t</italic>-test <italic>p</italic> = 0.02).</p>
                <p id="Par28">In summary, the allele-frequency analysis described above identified four genes: <italic>NRXN1</italic>, <italic>HTR2A</italic>, <italic>CTTNBP2</italic>, and <italic>REEP3</italic>. <italic>LIPH</italic> is excluded because its association is likely slightly inflated by LD and the genotyping in the second cohort did not reproduce as clearly. To validate the associations, we employed distinct strategies depending on whether the association was driven by coding (<italic>NRXN1</italic> and <italic>HTR2A</italic>) or regulatory variation (<italic>CTTNBP2</italic> and <italic>REEP3</italic>).</p>
              </sec>
              <sec id="Sec8">
                <title>Functional validation of regulatory variants using electrophoretic mobility shift assay</title>
                <p id="Par29">For <italic>CTTNBP2</italic> and <italic>REEP3</italic>, regulatory variants give a far stronger burden signal than does testing for either coding variants or all variants (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). Furthermore, the three largest effect variants in the combined cohort (1298 OCD cases and 1660 controls) alter enhancer elements in these two genes: chr7:117358107 in <italic>CTTNBP2</italic> (OR = 5.2) and chr10:65332906 (OR = 3.7) and chr10:65287863 (OR = 3.2) in <italic>REEP3</italic> (Supplementary Data <xref rid="MOESM6" ref-type="media">3</xref>). Using ENCODE and Roadmap Epigenomics data, we identified 17 candidate SNPs in <italic>CTTNBP2</italic> and <italic>REEP3</italic>, likely to alter transcription factor-binding sites (TFBS) and/or disrupt chromatin structure in brain-related cell types<sup><xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR29">29</xref></sup>. All 17 alter enhancers or transcription associated loci active in either the substantia nigra (SN), which relays signals from the striatum to the thalamus, and/or the dorsolateral prefrontal cortex (DL-PFC), which sends signals from the cortex to the striatum/thalamus (Fig. <xref rid="Fig3" ref-type="fig">3h, i</xref>). Both regions act in the CSTC pathway implicated by neurophysiological and genetic studies in OCD (Fig. <xref rid="Fig3" ref-type="fig">3j</xref>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p>
                <p id="Par30">We functionally tested 17 candidate regulatory SNPs in <italic>REEP3</italic> and <italic>CTTNBP2</italic> (Table <xref rid="Tab2" ref-type="table">2</xref>; Supplementary Fig. <xref rid="MOESM1" ref-type="media">7b</xref>). We introduced each into a human neuroblastoma cell line (SK-N-BE(2)) and assessed transcription factor binding using electrophoretic mobility shift assays (EMSA). Both DHS SNPs in <italic>REEP3</italic>, three of seven DHS SNPs in <italic>CTTNBP2</italic>, and one non-DHS variant in <italic>CTTNBP2</italic> clearly alter specific DNA-protein binding (Fig. <xref rid="Fig4" ref-type="fig">4a, b</xref>). We see weak evidence of differential binding for one upstream DHS SNP in <italic>REEP3</italic>, two DHS SNPs in <italic>CTTNBP2</italic>, and one non-DHS SNP in <italic>CTTNBP2</italic> (Supplementary Fig. <xref rid="MOESM1" ref-type="media">8</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Candidate regulatory variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr:pos</th><th>Ref</th><th>Alt</th><th>rsID</th><th>Transcription factor</th><th>EMSA</th><th>OR</th><th>GERP</th></tr></thead><tbody><tr><td colspan="8"><bold><italic>CTTNBP2</italic></bold></td></tr><tr><td> chr7:117356081</td><td>T</td><td>G</td><td>None</td><td>CTCF (GB, NB), RAD21 (NB, ESC)</td><td><sup>c</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr><tr><td> chr7:117390966</td><td>T</td><td>Del </td><td>None</td><td>CTCF (NB, CB), RAD21 (ESC)</td><td><sup>d</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr><tr><td> chr7:117417559</td><td>A</td><td>G</td><td>rs75322384</td><td><sup>b</sup></td><td><sup>c</sup></td><td>2.2</td><td>Conserved</td></tr><tr><td> chr7:117421141</td><td>C</td><td>A</td><td>None</td><td><sup>b</sup></td><td><sup>d</sup></td><td>Private<sup>e</sup>
</td><td>Conserved</td></tr><tr><td> chr7:117431202<sup>a</sup>
</td><td>C</td><td>A</td><td>None</td><td><sup>b</sup></td><td><sup>b</sup></td><td>Private<sup>e</sup>
</td><td>Conserved</td></tr><tr><td> chr7:117431704<sup>a</sup>
</td><td>C</td><td>T</td><td>None</td><td>RAD21 (ESC)</td><td><sup>d</sup></td><td>Private<sup>e</sup>
</td><td>Conserved</td></tr><tr><td> chr7:117431879<sup>a</sup>
</td><td>G</td><td>A</td><td>None</td><td><sup>b</sup></td><td><sup>c</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr><tr><td> chr7:117450810</td><td>C</td><td>T</td><td>rs34868515</td><td>SP1, YY1, EP300, JUND, TCF12, HDAC2, NANOG, BCL11A, TEAD4 (all ESC)</td><td><sup>b</sup></td><td>Private</td><td><sup>b</sup></td></tr><tr><td> chr7:117456904</td><td>C</td><td>T</td><td>rs12706157</td><td><sup>b</sup></td><td><sup>c</sup></td><td>1.06</td><td><sup>b</sup></td></tr><tr><td> chr7:117457141</td><td>G</td><td>C</td><td>rs13242822</td><td><sup>b</sup></td><td><sup>b</sup></td><td>1.04</td><td><sup>b</sup></td></tr><tr><td> chr7:117468056</td><td>C</td><td>T</td><td>rs2067080</td><td>EP300 (NB), FOXP2 (NB), JUND (ESC)</td><td><sup>b</sup></td><td>1.1</td><td>Conserved</td></tr><tr><td> chr7:117468334</td><td>T</td><td>C</td><td>rs2111209</td><td>EP300 (NB), FOXP2 (NB), JUND (ESC)</td><td><sup>b</sup></td><td>1.04</td><td><sup>b</sup></td></tr><tr><td colspan="8"><bold><italic>REEP3</italic></bold></td></tr><tr><td> chr10:65307923</td><td>A</td><td>G</td><td>rs78109635</td><td>GATA2 (NB)</td><td><sup>c</sup></td><td>1.01</td><td>Diverged</td></tr><tr><td> chr10:65332906</td><td>T</td><td>C</td><td>rs76646063</td><td>GATA3, GATA2, EP300 (all NB)</td><td><sup>c</sup></td><td>3.7</td><td>Conserved</td></tr><tr><td> chr10:65387644</td><td>C</td><td>G</td><td>rs56311840</td><td><sup>b</sup></td><td><sup>b</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr><tr><td> chr10:65387722</td><td>C</td><td>Del </td><td>None</td><td><sup>b</sup></td><td><sup>d</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr><tr><td> chr10:65388750</td><td>G</td><td>A</td><td>None</td><td>SIN3A (NB), POLR2A (NB), REST (NB), USF1 (ESC), EP300 (NB)</td><td><sup>b</sup></td><td>Private<sup>e</sup>
</td><td><sup>b</sup></td></tr></tbody></table><table-wrap-foot><p>We identified twelve candidate regulatory SNPs in <italic>CTTNBP2</italic>, including: seven intronic SNPs with DHS signals in neural stem cells (SK-N-MC) or neuroblasts (SK-N-SH, BE2-C, SH-SY5Y, SK-N-SH-RA), four of which also overlap TF-binding sites in the brain-derived cell lines; two intronic SNPs near the top DHS variants and potentially altering the same regulatory elements; and three coding SNPs that lie within or near regulatory marks (Supplementary Fig. <xref rid="MOESM1" ref-type="media">7b</xref>). We also identified five candidate regulatory SNPs in or near <italic>REEP3</italic>, including: one intronic SNP (chr10:65307923) in a DHS and GATA2 TFBS active in neuroblasts; one intronic SNP (chr10:65332906) that alters a DHS active in neural stem cells and GATA2, GATA3, and EP300 binding sites active in neuroblasts; three noncoding SNPs (chr10:65387644, chr10:65387722, and chr10:65388750) that cluster ~3 kb upstream in a DHS active in multiple brain-related cells, including neuroblasts, and are seen only in OCD patients in our pooled sequencing (Supplementary Fig. <xref rid="MOESM1" ref-type="media">7</xref>c) Del, deletion.</p><p><sup>a</sup>Coding; EMSA, electrophoretic mobility shift assay</p><p><sup>b</sup>No change</p><p><sup>c</sup>Strong TF-DNA binding change</p><p><sup>d</sup>Weak change; GB, glioblast; NB, neuroblast; ESC, embryonic stem cell; CB, cerebellum; “Transcription factor” column shows the TF bindings to the regions and brain/developmental cell types where the signals are found. OR (odds ratio) column reports data in the combined set, unless noted with</p><p><sup>e</sup>Indicating data from sequencing</p></table-wrap-foot></table-wrap>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Top genes validate in functional assays in context of known protein structure and in comparison to ExAC. EMSA of all 17 candidate regulatory variants in <bold>a</bold>
<italic>REEP3</italic> and <bold>b</bold>
<italic>CTTNBP2</italic> reveals that six variants either decrease (<italic>black arrows</italic>) or increase (<italic>red</italic>) protein binding when the variant sequence (MT) is compared with the reference allele (WT). The signal disappears when competing unlabeled probes (Cold+) are added, confirming the specificity of the DNA-protein binding. Raw images as well as EMSA results for experimental replicates and for other candidate regulatory variants that showed weak-binding changes are shown in Supplementary Fig. <xref rid="MOESM1" ref-type="media">8</xref>. <bold>c</bold> All seven of the candidate missense variants in <italic>NRXN1</italic>, shown here as <italic>colored</italic> elements, alter the extracellular postsynaptic-binding region of our top-scoring protein isoform NRXN1a-2 <sup><xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref></sup>. Of the six extracellular LNS (laminin, nectin, sex-hormone-binding globulin) domains in the longer isoform NRXN1a, five with known protein structure are shown and labeled L2-L6. NRXN1a-2 includes four of these domains (L2–L5; <italic>dashed ellipse</italic>). <bold>d</bold> The isoform-based test comparing OCD cases to ExAC finds <italic>NRXN1</italic> as the top-scoring gene with genome-wide significance. The ExAC analysis score is defined as the ratio of <italic>χ</italic>
<sup>2</sup> statistics (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathop {\sum}\nolimits_{i = 1}^n {\frac{{\left( {{\rm{O}}i - {\rm{E}}i} \right)}^{2}}{{{\rm{E}}i}}}$$\end{document}</tex-math><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mo> ∑</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mfenced close=")" open="(" separators=""><mml:mrow><mml:mi mathvariant="normal">O</mml:mi><mml:mi>i</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="normal">E</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="41467_2017_831_Article_IEq1.gif"/></alternatives></inline-formula>, where <italic>n</italic> = total number of isoforms, O<italic>i</italic> = number of non-reference alleles observed in isoform <italic>i</italic>, E<italic>i</italic> = number of non-reference alleles expected from ExAC in isoform <italic>i</italic>) between OCD vs. ExAC comparison and control vs. ExAC comparison</p></caption><graphic xlink:href="41467_2017_831_Fig4_HTML" id="d29e2825"/></fig>
</p>
                <p id="Par31">The high rate of functional validation by EMSA demonstrates that screening using both regulatory and evolutionary information is remarkably effective in identifying strong candidate OCD-risk variants. In total, eight of 12 tested DHS SNPs (67%) show evidence of altered protein binding, despite testing a single cell line at a single time point under standard-binding conditions (Table <xref rid="Tab2" ref-type="table">2</xref>). This includes two SNPs with high ORs in the full genotyping data sets that strongly disrupt specific DNA-protein binding (chr10:65332906 with OR = 3.7; chr7:117417559 with OR = 2.2). Two of five non-DHS SNPs (40%) also show altered binding, illustrating that DHS mark alone is a powerful but imperfect predictor of regulatory function. Both of these SNPs alter highly constrained elements (SiPhy score 8.7), whereas only one of the three non-DHS SNPs is constrained. Although this is a small data set, our results suggest that incorporating both DHS and conservation may identify functional regulatory variants with greater specificity, an observation consistent with previously published research<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
              </sec>
              <sec id="Sec9">
                <title>Validation of coding variants using ExAC</title>
                <p id="Par32">In contrast to the regulatory-variant burden found in <italic>CTTNBP2</italic> and <italic>REEP3</italic>, <italic>NRXN1</italic> and <italic>HTR2A</italic> showed significant PolyStrat signals when only coding variants are considered. Of 12 candidate coding SNPs in <italic>NRXN1</italic>, seven are missense (Table <xref rid="Tab3" ref-type="table">3</xref>). Four of these are SNPs private to OCD cases, and the other three are rare (AF in controls 0.0009–0.0036). All seven change amino acids in laminin G or EGF-like domains important for postsynaptic binding, potentially affecting the involvement of NRXN1 in synapse formation and maintenance (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>). Of the three candidate coding SNPs in <italic>HTR2A</italic>, two (one missense and one synonymous) are in the last coding exon, and one (missense) is the cytoplasmic domain with a PDZ-binding motif, potentially affecting binding affinity or specificity<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Coding variants in <italic>NRXN1</italic> and <italic>HTR2A</italic>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr:pos</th><th>Ref</th><th>Alt</th><th>rsID</th><th>OCD allele freq.</th><th>Ctrl allele freq.</th><th>ExAC allele freq.</th><th>Amino acid change</th><th>Candidate variant from sequencing</th></tr></thead><tbody><tr><td colspan="9"><italic>NRXN1</italic></td></tr><tr><td> chr2:50149133</td><td>C</td><td>T</td><td>rs113380721</td><td>0.0019</td><td>0.0030</td><td>0.0033</td><td>Syn</td><td>No</td></tr><tr><td> chr2:50149214</td><td>A</td><td>G</td><td>rs112536447</td><td>0.0001</td><td>0.0010</td><td>0.0003</td><td>Syn</td><td>No</td></tr><tr><td> chr2:50280604</td><td>T</td><td>C</td><td>rs79970751</td><td>0.0088</td><td>0.0070</td><td>0.0058</td><td>Syn</td><td>No</td></tr><tr><td> chr2:50463984</td><td>G</td><td>A</td><td>rs147580960</td><td>0.0009</td><td>0.0006</td><td>0</td><td>Syn</td><td>Yes</td></tr><tr><td> chr2:50464065</td><td>C</td><td>T</td><td>rs80094872</td><td>0.0009</td><td>0.0003</td><td>0<sup>a</sup>
</td><td>Syn</td><td>Yes</td></tr><tr><td> chr2:50699479</td><td>G</td><td>A</td><td>rs75275592</td><td>0.0009</td><td>0.0013</td><td>0.0010</td><td>Syn</td><td>No</td></tr><tr><td> chr2:50723068</td><td>G</td><td>A</td><td>rs56402642</td><td>0.0034</td><td>0.0001</td><td>0.0018</td><td>Syn</td><td>Yes</td></tr><tr><td> chr2:50724642</td><td>A</td><td>G</td><td>none</td><td>0.0009</td><td>0</td><td>0</td><td>I&gt;T</td><td>Yes</td></tr><tr><td> chr2:50724745</td><td>G</td><td>T</td><td>rs201818223</td><td>0.0017</td><td>0.0009</td><td>0.0011</td><td>L&gt;M</td><td>Yes</td></tr><tr><td> chr2:50733745</td><td>G</td><td>C</td><td>rs147984237</td><td>0.0017</td><td>0</td><td>1.5 × 10<sup>−5</sup>
</td><td>Syn</td><td>Yes</td></tr><tr><td> chr2:50765412</td><td>G</td><td>T</td><td>rs56086732</td><td>0.0089</td><td>0.0028</td><td>0.0056</td><td>L&gt;I</td><td>Yes</td></tr><tr><td> chr2:50765589</td><td>T</td><td>C</td><td>rs200074974</td><td>0.0016</td><td>0</td><td>0.0011</td><td>I&gt;V</td><td>Yes</td></tr><tr><td> chr2:50779791</td><td>C</td><td>T</td><td>None</td><td>0.0008</td><td>0</td><td>0<sup>a</sup>
</td><td>A&gt;T</td><td>Yes</td></tr><tr><td> chr2:50779943</td><td>T</td><td>C</td><td>None</td><td>0.0009</td><td>0</td><td>0<sup>a</sup>
</td><td>N&gt;S</td><td>Yes</td></tr><tr><td> chr2:50847195</td><td>G</td><td>A</td><td>rs78540316</td><td>0.0077</td><td>0.0036</td><td>0.0043</td><td>P&gt;S</td><td>Yes</td></tr><tr><td> chr2:50850686</td><td>G</td><td>A</td><td>rs2303298</td><td>0.0107</td><td>0.0013</td><td>0.0038</td><td>Syn</td><td>Yes</td></tr><tr><td colspan="9"><italic>HTR2A</italic></td></tr><tr><td> chr13:47409048</td><td>G</td><td>A</td><td>rs6308</td><td>0.0036</td><td>0.0012</td><td>0.0023</td><td>A&gt;V</td><td>Yes</td></tr><tr><td> chr13:47409701</td><td>G</td><td>A</td><td>rs141413930</td><td>0.0020</td><td>0.0012</td><td>0.0026<sup>a</sup>
</td><td>Syn</td><td>Yes</td></tr><tr><td> chr13:47409149</td><td>T</td><td>A</td><td>rs35224115</td><td>0.0019</td><td>0.0047</td><td>0.0044</td><td>Syn</td><td>No</td></tr><tr><td> chr13:47466622</td><td>G</td><td>A</td><td>rs6305</td><td>0.0386</td><td>0.0225</td><td>0.027<sup>b</sup>
</td><td>Syn</td><td>Yes</td></tr></tbody></table><table-wrap-foot><p>ExAC allele freq. shown for NFE population</p><p><sup>a</sup>Excluded from ExAC analysis because of low-confidence call from pooled sequencing</p><p><sup>b</sup>Excluded from ExAC analysis because of frequency &gt;0.01</p></table-wrap-foot></table-wrap>
</p>
                <p id="Par33">We sought to improve our statistical power by combining our pooled-sequencing data with publicly available ExAC data<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Using only our data, the associations of <italic>CTTNBP2</italic>, <italic>REEP3</italic>, <italic>NRXN1</italic>, and <italic>HTR2A</italic> with OCD are experiment-wide significant, but do not reach the genome-wide significance threshold <italic>p</italic> &lt; 2.5 × 10<sup>−6</sup> (~20,000 human genes), with the strongest association, to <italic>NRXN1</italic>, at <italic>p</italic> = 5.1 × 10<sup>−5</sup> (cohort 1 and 2; Fisher’s combined <italic>p</italic>). For the two genes with a burden of coding variants (<italic>NRXN1</italic> and <italic>HTR2A)</italic>, we used ExAC to assess variant burden in OCD cases compared with 33,370 non-Finnish Europeans. Such a comparison was not possible for <italic>CTTNBP2</italic> and <italic>REEP3</italic>, for which associated variants are predominantly noncoding and thus not assayed in ExAC.</p>
                <p id="Par34">To assess the significance of the variant enrichment in each gene, we used an isoform-based test that incorporates a within-gene comparison to assess significance, effectively controlling for inflation due to the extremely large size of the ExAC cohort<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> (Supplementary Methods). Of 542 genes with more than one isoform, we saw no significant difference between our control data and ExAC for over 90% (493 genes had corrected <italic>p</italic> &gt; 0.05). Focusing on the subset of 66 genes with nominally significant PolyStrat scores, <italic>NRXN1</italic> had the largest difference between cases and ExAC (<italic>χ</italic>
<sup>2</sup> = 82.3, df = 16, uncorrected <italic>p</italic> = 6.37 × 10<sup>−11</sup>; corrected <italic>p</italic> = 1.27 × 10<sup>−6</sup>) and no difference between controls and ExAC (<italic>χ</italic>
<sup>2</sup> = 10.5, df = 16, uncorrected <italic>p</italic> = 0.84) (Fig. <xref rid="Fig4" ref-type="fig">4d</xref>). No previous findings in OCD genetics have reached this level of significance despite &gt;100 candidate gene studies<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, a dozen linkage studies<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, and two GWAS<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref></sup>. <italic>HTR2A</italic>, while enriched for coding variants, had only two SNPs in cases, providing insufficient information for the isoform test.</p>
                <p id="Par35">The significant association of <italic>NRXN1</italic> reflects an exceptional burden of variants in one of its 17 Ensembl isoforms. <italic>NRXN1a-2</italic>, which contains all 12 candidate coding SNPs, had the largest deviation between observed and expected variant counts, with a residual at least 1.4× higher than any other isoform (<italic>NRXN1a-2</italic> = 22.3, <italic>NRXN1-001</italic> = 16.3; median = 5.15). After adjusting for the residuals from the “null” control data and ExAC comparison, the <italic>NRXN1a-2</italic> residual is still 1.3× higher (OCD residual/control residual <italic>NRXN1a-2</italic> = 5.34, <italic>NRXN1-014</italic> = 4.04).</p>
              </sec>
            </sec>
            <sec id="Sec10" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par36">By analyzing sequencing data for 608 OCD candidate genes, then prioritizing variants according to functional and conservation annotations, we identified four genes with a reproducible variant burden in OCD cases. Two genes, <italic>NRXN1</italic> and <italic>HTR2A</italic> (Table <xref rid="Tab3" ref-type="table">3</xref>), have a burden of coding variants, and the other two, <italic>CTTNBP2</italic> and <italic>REEP3</italic> (Table <xref rid="Tab2" ref-type="table">2</xref>), have a burden of conserved regulatory variants. Notably, all four act in neural pathways linked to OCD, including serotonin and glutamate signaling, synaptic connectivity, and the CSTC circuit<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, offering new insight into the biological basis of compulsive behavior (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>All four top candidate genes function at the synapse and interact with proteins implicated in OCD by previous studies in the three species. Human, dog, and mouse are marked with <italic>superscripts h</italic>, <italic>d</italic>, and <italic>m</italic>, respectively. Genes identified in this study are shown in <italic>red</italic>. <italic>Solid lines</italic> indicate direct interactions, and <italic>dashed lines</italic> indicate indirect interactions</p></caption><graphic xlink:href="41467_2017_831_Fig5_HTML" id="d29e3724"/></fig>
</p>
              <p id="Par37">We used three independent approaches to validate our findings: (1) For the top candidate SNPs, allele-frequency differences from sequencing data were confirmed by genotyping of both the original cohort (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>) and a larger, independent cohort (Fig. <xref rid="Fig3" ref-type="fig">3g</xref>). (2) For the two genes with a burden of coding variants (<italic>NRXN1</italic> and <italic>HTR2A)</italic>, comparison of our data to 33,370 population-matched controls from ExAC<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> revealed genome-wide-significant association of <italic>NRXN1</italic> with OCD. (3) For the two genes with the burden of regulatory variants (<italic>REEP3</italic> and <italic>CTTNBP2</italic>), more than one-third of candidate SNPs altered protein/DNA binding in a neuroblastoma cell line (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>).</p>
              <p id="Par38">Comparison of our approach to existing methods illustrates its unique advantages, and offers a deeper understanding of how its two key features—targeted sequencing, and incorporation of functional and conservation metrics—permit identification of significantly associated genes using a cohort smaller even than those that have previously failed to yield significant results.</p>
              <p id="Par39">Targeted sequencing captures both coding and regulatory variants, and both common and rare variants, at a fraction of the cost of whole-genome sequencing (WGS). For the modest-size cohort in this study, WGS would cost ~$2.5M, 40-fold more than our pooled-sequencing approach. Even without pooling, our targeted-sequencing costs fourfold less than WGS. Whole-exome sequencing would cost approximately the same as targeted sequencing, but misses the regulatory variants explaining most polygenic trait heritability<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. By using existing information on OCD and related diseases to prioritize a large set of genes, then performing targeted sequencing of functional elements, our approach enhances causal-variant detection and thus statistical power, although it misses OCD-associated genes not included as candidates, and potential distant regulatory elements.</p>
              <p id="Par40">The capacity to detect associations to rare variants is especially critical for study of diseases that, like OCD, may reduce fitness, as negative selection limits inheritance of deleterious variants<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Genotype array data sets, and even imputed data sets, miss many rare variants. In our data set, 80% of variants driving significant associations have allele frequencies &lt;0.05; one of the densest genotyping arrays available, the Illumina Infinium Omni5 (4.3M markers) contains only half of these variants (Supplementary Data <xref rid="MOESM4" ref-type="media">1</xref>)<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref></sup>. In addition, 60% of our variants have allele frequencies &lt;0.01, and would be missed even through imputation with 1000 Genomes and UK10K<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
              <p id="Par41">Our new analytical method, PolyStrat, analyzes targeted-sequencing data capturing all variants, and leverages public evolutionary and regulatory data to increase power. PolyStrat first filters out variants that are less likely to be functional, then performs gene-burden tests. In contrast to gene-based approaches focusing on ultra-rare, protein-damaging variants, PolyStrat considers variants of diverse frequencies, gaining power to identify genes with excess variants in cases.</p>
              <p id="Par42">PolyStrat is particularly advantageous when applied to studies with smaller cohorts. By testing for association at the gene level, it requires statistical correction only for the ~20,000 genes in the genome. It increases power further by using targeted-sequencing data to capture nearly all variation, including variants with higher allele frequencies and/or larger effect sizes, in regions that are coding or evolutionarily constrained, and enriching for causal variants by removing ~33% of variants unlikely to be functional<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. PolyStrat tests ~82 times more functional variants than PolyPhen2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), which focuses on protein-damaging variants (27,626 vs. 335 in our data).</p>
              <p id="Par43">Our PolyStrat results are consistent with expectations from simulations, which suggest that 200–700 cases should yield 90% power to detect associated genes with allele frequencies and effect sizes similar to our four genes<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Specifically, we would achieve 90% power to detect associations to <italic>NRXN1</italic> (combined AF = 0.022, OR = 2.4) with ~600 cases, to <italic>HTR2A</italic> (combined AF = 0.03, OR = 1.56) with ~700 cases; to <italic>REEP3</italic> (combined AF = 0.04, OR = 2.11) with ~200 cases, and to rare (AF &lt; 0.01) variants in <italic>CTTNBP2</italic> (combined AF = 0.003, OR = 4.7) with ~500 cases.</p>
              <p id="Par44">Previous research on the four genes identified by PolyStrat revealed that all are expressed in the striatum, a brain region linked to OCD (<ext-link ext-link-type="uri" xlink:href="http://human.brain-map.org/">http://human.brain-map.org/</ext-link>). All four genes are involved in pathways relevant to brain function, and harbor variants that could alter OCD risk (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Summary of top genes</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><italic>NRXN1</italic></th><th><italic>REEP3</italic></th><th><italic>CTTNBP2</italic></th><th><italic>HTR2A</italic></th></tr></thead><tbody><tr><td>Gene product/brain relevance</td><td>Synaptic cell-adhesion protein/synapse functioning and development in the cortical-striatal pathway<sup><xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref></sup>
</td><td>Microtubule-binding protein/possible role in synaptic plasticity, calcium signaling, shaping tubular ER membranes in neurons<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>
</td><td>Cortical actin (cortactin)-binding protein/synaptic maintenance<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>
</td><td>G-protein-coupled serotonin receptor/cortical neuron excitation<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>
</td></tr><tr><td>Disease relevance</td><td>Neurodevelopmental disorders incl. ASD<sup><xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR64">64</xref></sup>
</td><td>ASD<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>
</td><td>Interacts with CDH2, implicated in canine CD<sup><xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR65">65</xref></sup>
</td><td>ASD, OCD<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, canine CD (5-HT3 receptors)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>
</td></tr><tr><td>Reason for inclusion as candidate<sup>a</sup>
</td><td>(1) Model (mouse) organism gene; (2) ASD gene</td><td>(2) ASD gene</td><td>(1) Model (mouse) organism gene</td><td>(1) Model (dog) organism gene; (2) human candidate—SSRI target</td></tr><tr><td>Type of burden identified</td><td>Coding variants—missense variants over-represented to one isoform, <italic>NRXN1a-2</italic>
</td><td>Regulatory variants</td><td>Regulatory variants</td><td>Coding variants—missense variant in perfect linkage to a common variant rs6314 associated with response to SSRIs<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>
</td></tr><tr><td>Validation of variants identified in present study</td><td>By comparison to ExAC—genome-wide-significant association</td><td>By EMSA—disrupt regulatory elements bound by various TF, including GATA2</td><td>By EMSA—alter epigenetic marks active in the cortico-striatal pathway</td><td>By genotyping independent cohort; too few polymorphic sites for validation with ExAC</td></tr><tr><td>Hypothesized impact of variants identified</td><td>Inaccurate cellular localization of NRXN1, or altered binding competition to its partner, modifying synaptic adhesion<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>
</td><td>REEP3 expression in GABA neurons inhibited by variants that reduce GATA2 binding<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, leading to excitatory/inhibitory imbalance in CSTC circuit<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>
</td><td>Altered CTTNBP2 expression in cortical-striatal circuit in brain<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>
</td><td>Altered binding affinity of HTR2A, changing the activation of downstream calcium signaling in neurons<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>
</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>For explanation of each category, see “Results” section</p></table-wrap-foot></table-wrap>
</p>
              <p id="Par45"><italic>NRXN1</italic> encodes the synapse cell-adhesion protein neurexin 1α, a component of cortico-striatal neural pathway<sup><xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref></sup> implicated in ASD and other psychiatric diseases<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, and functionally related to genes associated with OCD (<italic>CDH9/CDH10</italic>)<sup><xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref></sup> and canine CD<sup><xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref></sup> (<italic>CDH2</italic>) (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). <italic>NRXN1</italic> isoforms are implicated in distinct neuropsychiatric disorders. The non-synonymous variants in the <italic>NRXN1a-2</italic> isoform (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>) may alter synaptic function by disrupting cellular localization or interactions with binding partners, including neurexophilins<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. The five synonymous candidate variants in likely regulatory elements may affect protein folding by disrupting post-transcriptional regulation, seen in other neuropsychiatic disorders<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>.</p>
              <p id="Par46">The synaptic plasticity gene <italic>REEP3</italic>, also implicated in ASD<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, encodes a protein that shapes tubular endoplasmic reticulum membranes found in highly polarized cells, including neurons<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. The two EMSA-validated <italic>REEP3</italic> variants change regulatory elements active in the cortico-striatal neural pathway (Fig. <xref rid="Fig3" ref-type="fig">3h</xref>) and bound by multiple TFs (Table <xref rid="Tab2" ref-type="table">2</xref>) including GATA2, which may be required to actuate inhibitory GABAergic neurons<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Thus, variants disrupting GATA2 binding could change the balance between excitatory and inhibitory neurons in the CSTC circuit (Fig. <xref rid="Fig3" ref-type="fig">3j</xref>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p>
              <p id="Par47"><italic>CTTNBP2</italic> regulates postsynaptic excitatory synapse formation. All four EMSA - confirmed variants in <italic>CTTNBP2</italic> alter epigenetic marks active in the key structures of the cortico-striatal neural pathway<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> (Table <xref rid="Tab2" ref-type="table">2</xref>; Fig. <xref rid="Fig3" ref-type="fig">3h</xref>), potentially affecting the expression of this critical gene. CTTNBP2 proteins interact with both proteins encoded by <italic>STRN</italic> (striatin), which approached experiment-wide significance in this study (uncorrected <italic>p</italic> = 0.0016, corrected <italic>p</italic> &lt; 0.1; Fig. <xref rid="Fig1" ref-type="fig">1b</xref>) and the canine CD gene <italic>CDH2</italic> (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).</p>
              <p id="Par48"><italic>HTR2A</italic> encodes a G-protein-coupled serotonin receptor expressed throughout the central nervous system, including in the prefrontal cortex, and has been implicated in ASD and OCD<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. A related serotonin-receptor cluster (<italic>HTR3C/HTR3D/HTR3E</italic>) is associated with severe canine CD<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>(Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The three coding variants found in <italic>HTR2A</italic> may alter its binding affinity (Table <xref rid="Tab3" ref-type="table">3</xref>)<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, and one of the three, a rare missense variant (rs6308; AF = 0.004 in 1000G CEU population) is perfectly linked (<italic>D</italic>′ = 1; <ext-link ext-link-type="uri" xlink:href="http://raggr.usc.edu">http://raggr.usc.edu</ext-link>) to a common variant (rs6314) associated with response to SSRIs<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>.</p>
              <p id="Par49">Taken together, our top four associated genes and our pathway analysis implicate three classes of neuronal functions in OCD, as described below.</p>
              <p id="Par50">First, synaptic cell-adhesion molecules help establish and maintain contact between the presynaptic and postsynaptic membrane, and are critical for synapse development and neural plasticity. <italic>NRXN1</italic> encodes a cell-adhesion molecule predominantly expressed in the brain, and <italic>CTTNBP2</italic> regulates cortactin, another such molecule, echoing earlier findings linking cell-adhesion genes to compulsive disorders in dogs (<italic>CDH2</italic> and <italic>CTNNA2</italic>), mice (<italic>Slitrk5)</italic>, and humans (<italic>DLGAP1</italic>, <italic>PTPRD</italic> and <italic>CDH9/CDH10</italic>)<sup><xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR51">51</xref></sup> (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). In our pathway analysis, “regulation of protein complex assembly” and “cytoskeleton organization” were enriched for variants in OCD patients.</p>
              <p id="Par51">Second, OCD may result from an imbalance of excitatory glutamate and inhibitory GABAergic neuron differentiation<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> (Fig. <xref rid="Fig3" ref-type="fig">3j</xref>), a process that involves both <italic>NRXN1</italic>
<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> and <italic>REEP3</italic>
<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> (Table <xref rid="Tab4" ref-type="table">4</xref>), as well as <italic>PTPRD</italic>, a top OCD GWAS candidate<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. We also find an overall burden of variants in genes regulating cell death and apoptosis (Supplementary Data <xref rid="MOESM5" ref-type="media">2</xref>) and in telencephalic tangential migration, a neuronal migration event which forms connections between the key structures of CSTC circuit<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>.</p>
              <p id="Par52">Third, SSRIs are the most effective available OCD treatment, suggesting a role for serotonergic pathways in disease. <italic>HTR2A</italic> encodes a serotonin receptor, and allelic variation in <italic>HTR2A</italic> alters response to SSRIs (Table <xref rid="Tab4" ref-type="table">4</xref>)<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. In addition, both <italic>REEP3</italic> and <italic>CACNA1C</italic>, which score high in this study (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), also significantly associate with schizophrenia and act in calcium signaling, a downstream pathway of <italic>HTR2A</italic>
<sup><xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR57">57</xref></sup>. Meta-analysis of &gt;100 OCD genetic association studies found strong association to both <italic>HTR2A</italic> and the serotonin transporter gene <italic>SLC6A4</italic>
<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. In dogs, a serotonin-receptor locus is associated with severe CD<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p>
              <p id="Par53">Our findings suggest broad principles that could guide studies of other polygenic diseases. We discovered that genes associated in selectively bred model organisms are more likely to contain rare, highly penetrant variants. The five genes we found to be most strongly associated with compulsive behaviors in dog and mouse (<italic>CDH2</italic>, <italic>CTNNA2</italic>, <italic>ATXN1</italic>, <italic>PGCP</italic>, and <italic>Sapap3</italic>) were significantly more enriched for rare variants in human patients than the other 603 genes targeted, although they did not individually achieve significance (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>). We propose that the enrichment of rare variants in humans reflects natural selective forces limiting the prevalence of severe disease-causing variants. Such forces are less powerful in selectively bred animal populations. Because risk variants identified through animal models are anticipated to be rare in humans, replication will require either family-based studies, or cohorts of magnitude not currently available.</p>
              <p id="Par54">We also find that the ratio of coding to regulatory variants is positively correlated with a gene’s developmental importance. Although single-gene <italic>p</italic>-values from PolyStrat tests are positively correlated across variant categories, as is expected given overlaps between different variant categories (Fig. <xref rid="Fig1" ref-type="fig">1a</xref>; Supplementary Fig. <xref rid="MOESM1" ref-type="media">9</xref>), this pattern breaks down for our four significantly associated genes. <italic>NRXN1</italic> and <italic>HTR2A</italic>, which have burdens of coding variants, score poorly on regulatory-variant tests; <italic>CTTNBP2</italic> and <italic>REEP3</italic>, which have burdens of regulatory variants, score poorly in coding-variant tests (Fig. <xref rid="Fig1" ref-type="fig">1b</xref>). This is consistent with the ExAC study showing that genes critical to viability or development do not tolerate major coding changes<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. In that study, the authors infer that <italic>CTTNBP2</italic> and <italic>REEP3</italic> would be intolerant of homozygous loss of function variants (<italic>p</italic>Rec = 0.99999015 and <italic>p</italic>Rec = 0.953842585, respectively), whereas <italic>HTR2A</italic> (<italic>p</italic>Rec = 0.225555783) and, most notably, <italic>NRXN1</italic> (<italic>p</italic>Rec = 5.13 × 10<sup>−5</sup>) would be far more tolerant. Our finding of enrichment for regulatory variants in <italic>CTTNBP2</italic> and <italic>REEP3</italic> suggests that these genes may tolerate variants with more subtle functional impacts, such as expression differences in specific cell types or developmental stages.</p>
              <p id="Par55">Technological advances in high-throughput sequencing bring increased focus on identifying causal genetic variants as a first step toward targeted disease therapies<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. However, existing approaches have notable limitations. WGS is prohibitively expensive in large cohorts, whereas cost-saving whole-exome sequencing does not capture the regulatory variants underlying complex diseases<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Leveraging existing genomic resources can increase power to find causal variants through meta-analysis and imputation, but these resources are heavily biased towards a few populations. Without new approaches, advances in precision medicine will predominantly benefit those of European descent.</p>
              <p id="Par56">Here, we describe an approach that combines prior findings, targeted sequencing, and a new analytic method to efficiently identify genes and individual variants associated with complex disease risk. In a modest-size cohort of OCD cases and controls we find associations driven by both coding and regulatory variants, highlighting new potential therapeutic targets. Our method holds promise for elucidating the biological basis of complex disease, and for extending the power of precision medicine to previously excluded populations.</p>
            </sec>
            <sec id="Sec11" sec-type="materials|methods">
              <title>Methods</title>
              <sec id="Sec12">
                <title>Study design</title>
                <p id="Par57">We designed and carried out the study in two phases. In the first, discovery phase, we performed targeted sequencing of 592 individuals with DSM-IV OCD and 560 controls of European ancestry, and tested association for OCD at single variant-level, gene-level, and pathway-level. In the second, validation phase, we employed three distinct analyses. (1) We genotyped both the original cohort and a second, independent cohort containing 1834 DNA samples (729 DSM-IV OCD cases and 1105 controls) of European ancestry, including a total of 2986 individuals (1321 OCD cases and 1665 controls) to confirm the observed allele frequencies in the discovery phase. (2) We compared our sequencing data with 33,370 population-matched controls from ExAC to confirm the gene-based burden of coding variants as well as allele frequencies. (3) We performed EMSA to test whether our candidate variants have regulatory function. Uses of biospecimens in this study were reviewed and approved by either the Broad's Office of Research Subject Protection, or the Partners HealthCare Human Research Committee. Informed consent was obtained from all subjects included in our study.</p>
              </sec>
              <sec id="Sec13">
                <title>Targeted regions</title>
                <p id="Par58">We targeted 82,723 evolutionarily constrained regions in and around 608 genes, which included all regions within 1 kb of the start and end of each of 608 targeted genes with SiPhy evolutionarily constraint score <italic>&gt;</italic>7, as well as all exons<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. For the intergenic regions upstream and downstream of each gene, we used constraint score thresholds that became more stringent with distance from the gene.</p>
              </sec>
              <sec id="Sec14">
                <title>Pooled sequencing and variant annotation</title>
                <p id="Par59">Groups of 16 individuals were pooled together into 37 case pools and 35 control pools and bar-coded. Targeted-genomic regions were captured using a custom NimbleGen hybrid capture array and sequenced by Illumina GAII or Illumina HiSeq2000. Sequencing reads were aligned and processed by Picard analysis pipeline (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>). Variants and AFs were called using Syzygy<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and SNVer<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. We used ANNOVAR<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> to annotate variants for RefSeq genes (hg19), GERP scores, ENCODE DHS cluster, and 1000 G data.</p>
              </sec>
              <sec id="Sec15">
                <title>Genotyping</title>
                <p id="Par60">SNP genotyping was performed using the Sequenom MassARRAY iPLEX platform. The resulting data were analyzed using PLINK1.9 (<ext-link ext-link-type="uri" xlink:href="http://www.cog-genomics.org/plink2">www.cog-genomics.org/plink2</ext-link>).</p>
              </sec>
              <sec id="Sec16">
                <title>EMSA</title>
                <p id="Par61">For each allele of the tested variants, pairs of 5′-biotinylated oligonucleotides were obtained from IDT Inc. (Supplementary Data <xref rid="MOESM7" ref-type="media">4</xref>). Equal volumes of forward and reverse oligonucleotides (1 pmol/µl) were mixed and heated at 95°C for 5 min and then cooled to room temperature. Annealed probes were incubated at room temperature for 30 min with SK-N-BE(2) nuclear extract (Active Motif). The remaining steps followed the LightShift Chemiluminescent EMSA Kit protocol (Thermo Scientific).</p>
              </sec>
              <sec id="Sec17">
                <title>Statistical analysis</title>
                <p id="Par62">For gene-association/pathway-association, we used the sum of the differences of non-reference allele rates between cases and controls per gene as test statistic, and calculated the probability of observing a test statistic by chance from 10,000 permutations. Multiple testing was empirically corrected using “minP” procedure. See Supplementary Methods for details.</p>
              </sec>
              <sec id="Sec18">
                <title>Code availability</title>
                <p id="Par63">The code used in this study was obtained from R package Rplinkseq and PLINK1.9.</p>
              </sec>
              <sec id="Sec19">
                <title>Data availability</title>
                <p id="Par64">All data presented in this study are accessible at: <ext-link ext-link-type="uri" xlink:href="https://data.broadinstitute.org/OCD_NatureCommunications2017/">https://data.broadinstitute.org/OCD_NatureCommunications2017/</ext-link>.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Electronic supplementary material</title>
              <sec id="Sec20">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41467_2017_831_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplementary Information</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="41467_2017_831_MOESM2_ESM.pdf">
                      <caption>
                        <p>Peer Review File</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM3">
                    <media xlink:href="41467_2017_831_MOESM3_ESM.pdf">
                      <caption>
                        <p>Supplementary Description</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM4">
                    <media xlink:href="41467_2017_831_MOESM4_ESM.xlsx">
                      <caption>
                        <p>Supplementary Data 1</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM5">
                    <media xlink:href="41467_2017_831_MOESM5_ESM.xlsx">
                      <caption>
                        <p>Supplementary Data 2</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM6">
                    <media xlink:href="41467_2017_831_MOESM6_ESM.xlsx">
                      <caption>
                        <p>Supplementary Data 3</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM7">
                    <media xlink:href="41467_2017_831_MOESM7_ESM.xlsx">
                      <caption>
                        <p>Supplementary Data 4</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>Elinor K. Karlsson and Kerstin Lindblad-Toh contributed equally to this work</p>
              </fn>
              <fn>
                <p>
                  <bold>Electronic supplementary material</bold>
                </p>
                <p><bold>Supplementary Information</bold> accompanies this paper at doi:10.1038/s41467-017-00831-x.</p>
              </fn>
              <fn>
                <p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank the participating individuals for their support, Eric S. Lander, Steven E. Hyman, Jessica Alföldi, and Kaitlin Samocha for valuable input; Leslie Gaffney for help with illustrations; Jeremiah M. Scharf for sample contribution and discussions; and Broad Genomics Platform for sample processing, sequencing, and genotyping. H.J.N. is supported by the AKC Health Foundation and Swedish Research Council, C.R. by the Swedish Research Council (K2013-61P-22168), K.L.-T. by the Swedish Medical Research Council and European Research Council, and E.K.K. by NIH NIMH (1R21MH109938-01). A Broad Institute SPARC grant supported part of this work.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>K.L.-T., E.K.K., G.F., H.J.N., and R.T. conceived and designed the experiments. H.J.N., R.T., E.K.K., J.F., C.O.’D., R.S., D.H., D.P.G., K.L.-T. analyzed the data. H.J.N., D.P.G., E.K.K., and K.L.-T. wrote the paper. R.T. and H.J.N. performed sequence capture. R.S. performed EMSA. M.W., H.-J.G., S.R., C.A.M., S.E.S., S.A.R., M.A.J., J.A.K., C.R., E.G., G.L.H., D.C.C., E.A., S.W., P.D.P., C.H., M.T.P., and C.N.P. diagnosed/collected samples. J.J., M.K., and G.v.G. coordinated/prepared samples and data generation.</p>
            </notes>
            <notes notes-type="COI-statement">
              <sec id="FPar1">
                <title>Competing interests</title>
                <p id="Par65">The authors declare is no competing financial interests.</p>
              </sec>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pauls</surname>
                      <given-names>DL</given-names>
                    </name>
                  </person-group>
                  <article-title>The genetics of obsessive-compulsive disorder: a review</article-title>
                  <source>Dialogues Clin. Neurosci.</source>
                  <year>2010</year>
                  <volume>12</volume>
                  <fpage>149</fpage>
                  <lpage>163</lpage>
                  <?supplied-pmid 20623920?>
                  <pub-id pub-id-type="pmid">20623920</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stewart</surname>
                      <given-names>SE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome-wide association study of obsessive-compulsive disorder</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2013</year>
                  <volume>18</volume>
                  <fpage>788</fpage>
                  <lpage>798</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2012.85</pub-id>
                  <?supplied-pmid 22889921?>
                  <pub-id pub-id-type="pmid">22889921</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mattheisen</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <fpage>337</fpage>
                  <lpage>344</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2014.43</pub-id>
                  <?supplied-pmid 24821223?>
                  <pub-id pub-id-type="pmid">24821223</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Welch</surname>
                      <given-names>JM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice</article-title>
                  <source>Nature</source>
                  <year>2007</year>
                  <volume>448</volume>
                  <fpage>894</fpage>
                  <lpage>900</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature06104</pub-id>
                  <?supplied-pmid 17713528?>
                  <pub-id pub-id-type="pmid">17713528</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmari</surname>
                      <given-names>SE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Repeated cortico-striatal stimulation generates persistent OCD-like behavior</article-title>
                  <source>Science</source>
                  <year>2013</year>
                  <volume>340</volume>
                  <fpage>1234</fpage>
                  <lpage>1239</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1234733</pub-id>
                  <?supplied-pmid 23744948?>
                  <pub-id pub-id-type="pmid">23744948</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ting</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics</article-title>
                  <source>Curr. Opin. Neurobiol.</source>
                  <year>2011</year>
                  <volume>21</volume>
                  <fpage>842</fpage>
                  <lpage>848</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.conb.2011.04.010</pub-id>
                  <?supplied-pmid 21605970?>
                  <pub-id pub-id-type="pmid">21605970</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karlsson</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Lindblad-Toh</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Leader of the pack: gene mapping in dogs and other model organisms</article-title>
                  <source>Nat. Rev. Genet.</source>
                  <year>2008</year>
                  <volume>9</volume>
                  <fpage>713</fpage>
                  <lpage>725</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrg2382</pub-id>
                  <?supplied-pmid 18714291?>
                  <pub-id pub-id-type="pmid">18714291</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Candidate genes and functional noncoding variants identified in a canine model of obsessive-compulsive disorder</article-title>
                  <source>Genome Biol.</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <fpage>R25</fpage>
                  <pub-id pub-id-type="doi">10.1186/gb-2014-15-3-r25</pub-id>
                  <?supplied-pmid 24995881?>
                  <pub-id pub-id-type="pmid">24995881</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dodman</surname>
                      <given-names>NH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A canine chromosome 7 locus confers compulsive disorder susceptibility</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2010</year>
                  <volume>15</volume>
                  <fpage>8</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2009.111</pub-id>
                  <?supplied-pmid 20029408?>
                  <pub-id pub-id-type="pmid">20029408</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sullivan</surname>
                      <given-names>PF</given-names>
                    </name>
                    <name>
                      <surname>Daly</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>O’Donovan</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic architectures of psychiatric disorders: the emerging picture and its implications</article-title>
                  <source>Nat. Rev. Genet.</source>
                  <year>2012</year>
                  <volume>13</volume>
                  <fpage>537</fpage>
                  <lpage>551</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrg3240</pub-id>
                  <?supplied-pmid 22777127?>
                  <pub-id pub-id-type="pmid">22777127</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Farrell</surname>
                      <given-names>MS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluating historical candidate genes for schizophrenia</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2015</year>
                  <volume>20</volume>
                  <fpage>555</fpage>
                  <lpage>562</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2015.16</pub-id>
                  <?supplied-pmid 25754081?>
                  <pub-id pub-id-type="pmid">25754081</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sobrin</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe)</article-title>
                  <source>Invest. Ophthalmol. Vis. Sci.</source>
                  <year>2011</year>
                  <volume>52</volume>
                  <fpage>7593</fpage>
                  <lpage>7602</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.11-7510</pub-id>
                  <?supplied-pmid 21873659?>
                  <pub-id pub-id-type="pmid">21873659</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fuchsberger</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The genetic architecture of type 2 diabetes</article-title>
                  <source>Nature</source>
                  <year>2016</year>
                  <volume>536</volume>
                  <fpage>41</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature18642</pub-id>
                  <?supplied-pmid 27398621?>
                  <pub-id pub-id-type="pmid">27398621</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>D’Gama</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms</article-title>
                  <source>Neuron</source>
                  <year>2015</year>
                  <volume>88</volume>
                  <fpage>910</fpage>
                  <lpage>917</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuron.2015.11.009</pub-id>
                  <?supplied-pmid 26637798?>
                  <pub-id pub-id-type="pmid">26637798</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bertram</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Tanzi</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <article-title>Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2008</year>
                  <volume>9</volume>
                  <fpage>768</fpage>
                  <lpage>778</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrn2494</pub-id>
                  <?supplied-pmid 18802446?>
                  <pub-id pub-id-type="pmid">18802446</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cohen</surname>
                      <given-names>JC</given-names>
                    </name>
                    <name>
                      <surname>Boerwinkle</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Mosley</surname>
                      <given-names>TH</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Hobbs</surname>
                      <given-names>HH</given-names>
                    </name>
                  </person-group>
                  <article-title>Sequence variations in PCSK9, low LDL, and protection against coronary heart disease</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2006</year>
                  <volume>354</volume>
                  <fpage>1264</fpage>
                  <lpage>1272</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa054013</pub-id>
                  <?supplied-pmid 16554528?>
                  <pub-id pub-id-type="pmid">16554528</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rivas</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease</article-title>
                  <source>Nat. Genet.</source>
                  <year>2011</year>
                  <volume>43</volume>
                  <fpage>1066</fpage>
                  <lpage>1073</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.952</pub-id>
                  <?supplied-pmid 21983784?>
                  <pub-id pub-id-type="pmid">21983784</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierrez-Achury</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease</article-title>
                  <source>Nat. Genet.</source>
                  <year>2015</year>
                  <volume>47</volume>
                  <fpage>577</fpage>
                  <lpage>578</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.3268</pub-id>
                  <?supplied-pmid 25894500?>
                  <pub-id pub-id-type="pmid">25894500</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roth</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>McKenney</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Hanotin</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Asset</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Stein</surname>
                      <given-names>EA</given-names>
                    </name>
                  </person-group>
                  <article-title>Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2012</year>
                  <volume>367</volume>
                  <fpage>1891</fpage>
                  <lpage>1900</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1201832</pub-id>
                  <?supplied-pmid 23113833?>
                  <pub-id pub-id-type="pmid">23113833</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warr</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Exome sequencing: current and future perspectives</article-title>
                  <source>G3</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>1543</fpage>
                  <lpage>1550</lpage>
                  <pub-id pub-id-type="doi">10.1534/g3.115.018564</pub-id>
                  <?supplied-pmid 26139844?>
                  <pub-id pub-id-type="pmid">26139844</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Finucane</surname>
                      <given-names>HK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title>
                  <source>Nat. Genet.</source>
                  <year>2015</year>
                  <volume>47</volume>
                  <fpage>1228</fpage>
                  <lpage>1235</lpage>
                  <pub-id pub-id-type="doi">10.1038/ng.3404</pub-id>
                  <?supplied-pmid 26414678?>
                  <pub-id pub-id-type="pmid">26414678</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lindblad-Toh</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A high-resolution map of human evolutionary constraint using 29 mammals</article-title>
                  <source>Nature</source>
                  <year>2011</year>
                  <volume>478</volume>
                  <fpage>476</fpage>
                  <lpage>482</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature10530</pub-id>
                  <?supplied-pmid 21993624?>
                  <pub-id pub-id-type="pmid">21993624</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wei</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Lyon</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Hakonarson</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2011</year>
                  <volume>39</volume>
                  <fpage>e132</fpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkr599</pub-id>
                  <?supplied-pmid 21813454?>
                  <pub-id pub-id-type="pmid">21813454</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pruitt</surname>
                      <given-names>KD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>RefSeq: an update on mammalian reference sequences</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2014</year>
                  <volume>42</volume>
                  <fpage>D756</fpage>
                  <lpage>63</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkt1114</pub-id>
                  <?supplied-pmid 24259432?>
                  <pub-id pub-id-type="pmid">24259432</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hakonarson</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2010</year>
                  <volume>38</volume>
                  <fpage>e164</fpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
                  <?supplied-pmid 20601685?>
                  <pub-id pub-id-type="pmid">20601685</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dunham</surname>
                      <given-names>I</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
                  <source>Nature</source>
                  <year>2012</year>
                  <volume>489</volume>
                  <fpage>57</fpage>
                  <lpage>74</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
                  <pub-id pub-id-type="pmid">22955616</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davydov</surname>
                      <given-names>EV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>
                  <source>PLoS Comput. Biol.</source>
                  <year>2010</year>
                  <volume>6</volume>
                  <fpage>e1001025</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id>
                  <?supplied-pmid 21152010?>
                  <pub-id pub-id-type="pmid">21152010</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>The 1000 Genomes Project Consortium.</collab>
                  </person-group>
                  <article-title>A global reference for human genetic variation</article-title>
                  <source>Nature</source>
                  <year>2015</year>
                  <volume>526</volume>
                  <fpage>68</fpage>
                  <lpage>74</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
                  <pub-id pub-id-type="pmid">26432245</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Roadmap Epigenomics Consortium</collab>
                    <etal/>
                  </person-group>
                  <article-title>Integrative analysis of 111 reference human epigenomes</article-title>
                  <source>Nature</source>
                  <year>2015</year>
                  <volume>518</volume>
                  <fpage>317</fpage>
                  <lpage>330</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature14248</pub-id>
                  <pub-id pub-id-type="pmid">25693563</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pauls</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Abramovitch</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rauch</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Geller</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2014</year>
                  <volume>15</volume>
                  <fpage>410</fpage>
                  <lpage>424</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrn3746</pub-id>
                  <?supplied-pmid 24840803?>
                  <pub-id pub-id-type="pmid">24840803</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kheradpour</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay</article-title>
                  <source>Genome Res.</source>
                  <year>2013</year>
                  <volume>23</volume>
                  <fpage>800</fpage>
                  <lpage>811</lpage>
                  <pub-id pub-id-type="doi">10.1101/gr.144899.112</pub-id>
                  <?supplied-pmid 23512712?>
                  <pub-id pub-id-type="pmid">23512712</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Becamel</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2004</year>
                  <volume>279</volume>
                  <fpage>20257</fpage>
                  <lpage>20266</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M312106200</pub-id>
                  <?supplied-pmid 14988405?>
                  <pub-id pub-id-type="pmid">14988405</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lek</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
                  <source>Nature</source>
                  <year>2016</year>
                  <volume>536</volume>
                  <fpage>285</fpage>
                  <lpage>291</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
                  <?supplied-pmid 27535533?>
                  <pub-id pub-id-type="pmid">27535533</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schneider</surname>
                      <given-names>JW</given-names>
                    </name>
                  </person-group>
                  <article-title>Caveats for using statistical significance tests in research assessments</article-title>
                  <source>J. Informetr.</source>
                  <year>2013</year>
                  <volume>7</volume>
                  <fpage>50</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.joi.2012.08.005</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taylor</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2013</year>
                  <volume>18</volume>
                  <fpage>799</fpage>
                  <lpage>805</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2012.76</pub-id>
                  <?supplied-pmid 22665263?>
                  <pub-id pub-id-type="pmid">22665263</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Park</surname>
                      <given-names>J-H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants</article-title>
                  <source>Proc. Natl Acad. Sci. USA</source>
                  <year>2011</year>
                  <volume>108</volume>
                  <fpage>18026</fpage>
                  <lpage>18031</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1114759108</pub-id>
                  <?supplied-pmid 22003128?>
                  <pub-id pub-id-type="pmid">22003128</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel</article-title>
                  <source>Nat. Commun.</source>
                  <year>2015</year>
                  <volume>6</volume>
                  <fpage>8111</fpage>
                  <pub-id pub-id-type="doi">10.1038/ncomms9111</pub-id>
                  <?supplied-pmid 26368830?>
                  <pub-id pub-id-type="pmid">26368830</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>MC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Rare-variant association testing for sequencing data with the sequence kernel association test</article-title>
                  <source>Am. J. Hum. Genet.</source>
                  <year>2011</year>
                  <volume>89</volume>
                  <fpage>82</fpage>
                  <lpage>93</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.05.029</pub-id>
                  <?supplied-pmid 21737059?>
                  <pub-id pub-id-type="pmid">21737059</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zuk</surname>
                      <given-names>O</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Searching for missing heritability: designing rare variant association studies</article-title>
                  <source>Proc. Natl Acad. Sci. USA</source>
                  <year>2014</year>
                  <volume>111</volume>
                  <fpage>E455</fpage>
                  <lpage>64</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1322563111</pub-id>
                  <?supplied-pmid 24443550?>
                  <pub-id pub-id-type="pmid">24443550</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Wit</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation</article-title>
                  <source>Neuron</source>
                  <year>2009</year>
                  <volume>64</volume>
                  <fpage>799</fpage>
                  <lpage>806</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuron.2009.12.019</pub-id>
                  <?supplied-pmid 20064388?>
                  <pub-id pub-id-type="pmid">20064388</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Surmeier</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Ding</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Day</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons</article-title>
                  <source>Trends Neurosci.</source>
                  <year>2007</year>
                  <volume>30</volume>
                  <fpage>228</fpage>
                  <lpage>235</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tins.2007.03.008</pub-id>
                  <?supplied-pmid 17408758?>
                  <pub-id pub-id-type="pmid">17408758</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sudhof</surname>
                      <given-names>TC</given-names>
                    </name>
                  </person-group>
                  <article-title>Neuroligins and neurexins link synaptic function to cognitive disease</article-title>
                  <source>Nature</source>
                  <year>2008</year>
                  <volume>455</volume>
                  <fpage>903</fpage>
                  <lpage>911</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature07456</pub-id>
                  <?supplied-pmid 18923512?>
                  <pub-id pub-id-type="pmid">18923512</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rujescu</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Disruption of the neurexin 1 gene is associated with schizophrenia</article-title>
                  <source>Hum. Mol. Genet</source>
                  <year>2009</year>
                  <volume>18</volume>
                  <fpage>988</fpage>
                  <lpage>996</lpage>
                  <pub-id pub-id-type="doi">10.1093/hmg/ddn351</pub-id>
                  <?supplied-pmid 18945720?>
                  <pub-id pub-id-type="pmid">18945720</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Takata</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ionita-Laza</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Gogos</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Karayiorgou</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>De novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia</article-title>
                  <source>Neuron</source>
                  <year>2016</year>
                  <volume>89</volume>
                  <fpage>940</fpage>
                  <lpage>947</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.024</pub-id>
                  <?supplied-pmid 26938441?>
                  <pub-id pub-id-type="pmid">26938441</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Castermans</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Identification and characterization of the TRIP8 and REEP3 genes on chromosome 10q21.3 as novel candidate genes for autism</article-title>
                  <source>Eur. J. Hum. Genet.</source>
                  <year>2007</year>
                  <volume>15</volume>
                  <fpage>422</fpage>
                  <lpage>431</lpage>
                  <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201785</pub-id>
                  <?supplied-pmid 17290275?>
                  <pub-id pub-id-type="pmid">17290275</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blackstone</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>O’Kane</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Reid</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Hereditary spastic paraplegias: membrane traffic and the motor pathway</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>31</fpage>
                  <lpage>42</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrn2990</pub-id>
                  <?supplied-pmid 21139634?>
                  <pub-id pub-id-type="pmid">21139634</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kala</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons</article-title>
                  <source>Development</source>
                  <year>2009</year>
                  <volume>136</volume>
                  <fpage>253</fpage>
                  <lpage>262</lpage>
                  <pub-id pub-id-type="doi">10.1242/dev.029900</pub-id>
                  <?supplied-pmid 19088086?>
                  <pub-id pub-id-type="pmid">19088086</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>YK</given-names>
                    </name>
                    <name>
                      <surname>Hsueh</surname>
                      <given-names>YP</given-names>
                    </name>
                  </person-group>
                  <article-title>Cortactin-binding protein 2 modulates the mobility of cortactin and regulates dendritic spine formation and maintenance</article-title>
                  <source>J. Neurosci.</source>
                  <year>2012</year>
                  <volume>32</volume>
                  <fpage>1043</fpage>
                  <lpage>1055</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4405-11.2012</pub-id>
                  <?supplied-pmid 22262902?>
                  <pub-id pub-id-type="pmid">22262902</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dodman</surname>
                      <given-names>NH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genomic risk for severe canine compulsive disorder, a dog model of human OCD</article-title>
                  <source>Int. J. Appl. Res. Vet. Med.</source>
                  <year>2016</year>
                  <volume>14</volume>
                  <fpage>1</fpage>
                  <lpage>18</lpage>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Porcelli</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pharmacogenetics of antidepressant response</article-title>
                  <source>J. Psychiatry Neurosci.</source>
                  <year>2011</year>
                  <volume>36</volume>
                  <fpage>87</fpage>
                  <lpage>113</lpage>
                  <pub-id pub-id-type="doi">10.1503/jpn.100059</pub-id>
                  <?supplied-pmid 21172166?>
                  <pub-id pub-id-type="pmid">21172166</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shmelkov</surname>
                      <given-names>SV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice</article-title>
                  <source>Nat. Med.</source>
                  <year>2010</year>
                  <volume>16</volume>
                  <fpage>598</fpage>
                  <lpage>602</lpage>
                  <pub-id pub-id-type="doi">10.1038/nm.2125</pub-id>
                  <?supplied-pmid 20418887?>
                  <pub-id pub-id-type="pmid">20418887</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Graf</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>SX</given-names>
                    </name>
                    <name>
                      <surname>Linhoff</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Craig</surname>
                      <given-names>AM</given-names>
                    </name>
                  </person-group>
                  <article-title>Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins</article-title>
                  <source>Cell</source>
                  <year>2004</year>
                  <volume>119</volume>
                  <fpage>1013</fpage>
                  <lpage>1026</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cell.2004.11.035</pub-id>
                  <?supplied-pmid 15620359?>
                  <pub-id pub-id-type="pmid">15620359</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doly</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Marullo</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Gatekeepers controlling GPCR export and function</article-title>
                  <source>Trends Pharmacol. Sci.</source>
                  <year>2015</year>
                  <volume>36</volume>
                  <fpage>636</fpage>
                  <lpage>644</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tips.2015.06.007</pub-id>
                  <?supplied-pmid 26435209?>
                  <pub-id pub-id-type="pmid">26435209</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Marin</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Rubenstein</surname>
                      <given-names>JL</given-names>
                    </name>
                  </person-group>
                  <article-title>A long, remarkable journey: tangential migration in the telencephalon</article-title>
                  <source>Nat. Rev. Neurosci.</source>
                  <year>2001</year>
                  <volume>2</volume>
                  <fpage>780</fpage>
                  <lpage>790</lpage>
                  <pub-id pub-id-type="doi">10.1038/35097509</pub-id>
                  <?supplied-pmid 11715055?>
                  <pub-id pub-id-type="pmid">11715055</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>
                  </person-group>
                  <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
                  <source>Nature</source>
                  <year>2014</year>
                  <volume>511</volume>
                  <fpage>421</fpage>
                  <lpage>427</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
                  <pub-id pub-id-type="pmid">25056061</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schwarz</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Blower</surname>
                      <given-names>MD</given-names>
                    </name>
                  </person-group>
                  <article-title>The endoplasmic reticulum: structure, function and response to cellular signaling</article-title>
                  <source>Cell Mol. Life Sci.</source>
                  <year>2016</year>
                  <volume>73</volume>
                  <fpage>79</fpage>
                  <lpage>94</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00018-015-2052-6</pub-id>
                  <?supplied-pmid 26433683?>
                  <pub-id pub-id-type="pmid">26433683</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <mixed-citation publication-type="other">The UniProt Consortium. UniProtKB—P28223 (5HT2A_HUMAN). <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/uniprot/P28223">http://www.uniprot.org/uniprot/P28223</ext-link>. Accessed 8th August (2016)</mixed-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ashley</surname>
                      <given-names>EA</given-names>
                    </name>
                  </person-group>
                  <article-title>Towards precision medicine</article-title>
                  <source>Nat. Rev. Genet.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <fpage>507</fpage>
                  <lpage>522</lpage>
                  <pub-id pub-id-type="doi">10.1038/nrg.2016.86</pub-id>
                  <?supplied-pmid 27528417?>
                  <pub-id pub-id-type="pmid">27528417</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Niknafs</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures</article-title>
                  <source>Hum. Genet.</source>
                  <year>2013</year>
                  <volume>132</volume>
                  <fpage>1235</fpage>
                  <lpage>1243</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00439-013-1325-0</pub-id>
                  <?supplied-pmid 23793516?>
                  <pub-id pub-id-type="pmid">23793516</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Venugopal</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Rudenko</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>The structure of neurexin 1α reveals features promoting a role as synaptic organizer</article-title>
                  <source>Structure</source>
                  <year>2011</year>
                  <volume>19</volume>
                  <fpage>779</fpage>
                  <lpage>789</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.str.2011.03.012</pub-id>
                  <?supplied-pmid 21620716?>
                  <pub-id pub-id-type="pmid">21620716</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>NCBI Resource Coordinators</collab>
                  </person-group>
                  <article-title>Database resources of the National Center for Biotechnology Information</article-title>
                  <source>Nucleic Acids Res.</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <fpage>D7</fpage>
                  <lpage>D19</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv1290</pub-id>
                  <pub-id pub-id-type="pmid">26615191</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y-K</given-names>
                    </name>
                    <name>
                      <surname>Y.-K.</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Y.-P.</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>cortactin-binding protein 2 modulates the mobility of cortactin and regulates dendritic spine formation and maintenance</article-title>
                  <source>J. Neurosci.</source>
                  <year>2012</year>
                  <volume>32</volume>
                  <fpage>1043</fpage>
                  <lpage>1055</lpage>
                  <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4405-11.2012</pub-id>
                  <?supplied-pmid 22262902?>
                  <pub-id pub-id-type="pmid">22262902</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lambe</surname>
                      <given-names>EK</given-names>
                    </name>
                    <name>
                      <surname>Fillman</surname>
                      <given-names>SG</given-names>
                    </name>
                    <name>
                      <surname>Webster</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Shannon Weickert</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development</article-title>
                  <source>PLoS ONE</source>
                  <year>2011</year>
                  <volume>6</volume>
                  <fpage>e22799</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0022799</pub-id>
                  <?supplied-pmid 21829518?>
                  <pub-id pub-id-type="pmid">21829518</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jenkins</surname>
                      <given-names>AK</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging</article-title>
                  <source>Mol. Psychiatry</source>
                  <year>2016</year>
                  <volume>21</volume>
                  <fpage>701</fpage>
                  <lpage>706</lpage>
                  <pub-id pub-id-type="doi">10.1038/mp.2015.107</pub-id>
                  <?supplied-pmid 26216298?>
                  <pub-id pub-id-type="pmid">26216298</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>El Sayegh</surname>
                      <given-names>TY</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cortactin associates with N-cadherin adhesions and mediates intercellular adhesion strengthening in fibroblasts</article-title>
                  <source>J. Cell Sci.</source>
                  <year>2004</year>
                  <volume>117</volume>
                  <fpage>5117</fpage>
                  <lpage>5131</lpage>
                  <pub-id pub-id-type="doi">10.1242/jcs.01385</pub-id>
                  <?supplied-pmid 15383621?>
                  <pub-id pub-id-type="pmid">15383621</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>YK</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>CY</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>HT</given-names>
                    </name>
                  </person-group>
                  <article-title>CTTNBP2, but not CTTNBP2NL, regulates dendritic spinogenesis and synaptic distribution of the striatin–PP2A complex</article-title>
                  <source>Mol. Biol. Cell</source>
                  <year>2012</year>
                  <volume>23</volume>
                  <fpage>4383</fpage>
                  <lpage>4392</lpage>
                  <pub-id pub-id-type="doi">10.1091/mbc.E12-05-0365</pub-id>
                  <?supplied-pmid 23015759?>
                  <pub-id pub-id-type="pmid">23015759</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
